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ABSTRACT 
 
TITLE:  
To study the sociodemographic, microbio-pathological, clinico-radiological profile and 
etiology of patients with non-resolving pneumonia in a tertiary care hospital. 
 
AIMS & OBJECTIVES:  
 To study the  
SOCIODEMOGRAPHIC PROFILE 
CLINICO-RADIOLOGICAL PROFILE and 
MICROBIO-PATHOLOGICAL ETIOLOGY 
      of patients admitted with Non-resolving pneumonia in a Tertiary care hospital. 
 To study the co morbidities associated with non-resolving pneumonia. 
 To study the usefulness/diagnostic yield of bronchoscopy in non-resolving 
pneumonia. 
 To study the usefulness of Bronchial wash gene-xpert in diagnosing tuberculosis 
in non-resolving pneumonia. 
 To compare Bronchial wash gene-xpert Vs. Bronchial wash AFB (Acid Fast 
Bacilli) smear in diagnosing tuberculosis in non-resolving pneumonia. 
 To compare Bronchial wash gene-xpert Vs. Post bronchoscopy sputum AFB 
smear in diagnosing tuberculosis in non-resolving pneumonia. 
 
CASE DEFINITION: 
“Non-resolving pneumonia is defined as a clinical condition wherein there is radiological 
infiltrates (focal or diffuse, unilateral or bilateral, parenchymal or interstitial) begin with 
clinical association of acute pulmonary infection and with a minimum 10 days of 
standard antimicrobial therapy, patients either fail to improve or worsen, or radiological 
opacities fail to resolve by 50% at 2 weeks or less than complete clearing at 4 weeks.” 
 
MATERIALS/METHODS:  
A total of 420 patients were admitted with provisional diagnosis of pneumonia during the 
study period. Out of them 55 patients (13%) diagnosed to have non-resolving pneumonia 
were evaluated. Sociodemographic data, detailed history, clinical examination, routine 
investigations, chest skiagram, CT chest and other relevant investigations were done. 
Bronchoscopy (FOB) and bronchial wash was done in all patients and sent for gene-xpert 
and other microbio-pathological investigations. Post bronchoscopy sputum was sent for 
AFB smear and cytology. Endobronchial biopsy, Trans Bronchial Lung Biopsy (TBLB), 
CT guided biopsy as necessary were done in selected patients.  
 
RESULTS:  
Out of 55 patients, 80% (n=44) were males, 20% (n=11) were females. 78.2% (n=43) 
patients were more than 40 years. The most common presenting symptom was persistent 
cough with expectoration in 54.5% (n=30) patients, followed by dyspnea in 16.4% (n=9) 
patients. Chest pain followed by hemoptysis were the cardinal symptoms when cause for 
NRP is diagnosed as malignancy, (P-value 0.000). The average duration of symptom is 
7.5 weeks and in cases diagnosed with tuberculosis it is 6.5 weeks (P-value 0.000). 
47.3% were smokers and 54.5% patients had a history of chronic alcohol intake. 
Comorbidities were present in 82% (n=45) of patients. Among the patients with 
comorbidities, diabetes was present in 40%, COPD in 22.22%, renal failure in 6.67%, 
anemia in 6.67%, bronchial asthma in 4.44% and other comorbidities in 20%. 5 out of 10 
patients (50%) with COPD were diagnosed with malignancy (P-value 0.000) and 50% of 
patients with diabetes were diagnosed with tuberculosis (P-value 0.024). Left upper lobe 
is most commonly involved, followed by right upper lobe and diffuse involvement. 
Bronchoscopy was diagnostic in 39/55 cases, the yield being 71%. Bronchial wash gene-
xpert was positive (MTB DETECTED) in 23 patients (41.8%) and all patients had a 
result of Rifampicin resistance-Not detected. Bronchial wash AFB smear was positive in 
12 out of 55 patients and Post FOB sputum AFB was positive in 4 out of 55 patients. 
Causes diagnosed were tuberculosis 41.8% (n=23), other bacterial pneumonia 14.5% 
(n=8), malignancy 12.7% (n=7), others 23.7% (n=13) and undiagnosed 7.3% (n=4).  
CONCLUSION :  
 Non-resolving pneumonia was observed to be more common in patients >40 years 
of age which constitutes around 80% of study population.  
 The most common presenting symptom was persistent cough with expectoration.  
 Chest pain followed by hemoptysis were the presenting symptoms when cause for 
non-resolving pneumonia was diagnosed as malignancy.  
 In our study smoking and alcoholism was found to be associated with non-
resolving pneumonia in 47% patients and 55% patients respectively.  
 Non resolving pneumonia was found to be associated with co morbidities in 
around 80% of our study population. Diabetes mellitus (40%) and COPD (22%) 
were the most common co morbidities. Non resolving pneumonia in diabetic 
patients is more likely to be tuberculosis with 50% of diabetics in our study were 
diagnosed with tuberculosis. Non resolving pneumonia in COPD patients, is an 
ominous sign, more chances of it being diagnosed as malignancy.  
 Bronchoscopy was found to be a safe and useful procedure in non-resolving 
pneumonia patients and no serious complications were encountered. The 
diagnostic yield of bronchoscopy in our study was 71%.  
 Tuberculosis was the most common cause for non-resolving pneumonia in around 
42% of patients. Bacterial pneumonia (15%) and malignancy (15%) were the next 
two causes.  
 Bronchial wash Gene Xpert, as a single investigation has a diagnostic yield of 
around 42% in non-resolving pneumonia. Bronchial wash Gene Xpert has an 
additional yield of 48% in diagnosing tuberculosis against bronchial wash AFB 
smear. Bronchial wash Gene Xpert has an additional yield of 83% in diagnosing 
tuberculosis against Post Bronchoscopy sputum AFB smear. Our study suggests 
that Bronchial wash Gene Xpert can be included in the non-resolving pneumonia 
investigation panel, because it has a good diagnostic yield and provides an early 
diagnosis of tuberculosis before the patient becomes bronchial wash AFB or 
sputum AFB smear positive.  
 Early bronchoscopy (after 2 weeks of antibiotics), is needed in non-resolving 
pneumonia for early diagnosis of tuberculosis. 
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INTRODUCTION 
Community-acquired pneumonia (CAP) is one among the many acute 
medical conditions that require hospitalisation.1 Majority of patients 
hospitalised with community acquired pneumonia respond well to the standard 
antimicrobial therapy and follow an uncomplicated course but a minority or 
small proportion of patients fail to respond and require further investigations 
and treatment.2 3 Even with the advances in clinical care, the mortality rate with 
community acquired pneumonia remains around five to fifteen percentage.4 5 
Patients with non-responding or progressive pneumonia represent a group of 
patients in whom early appropriate intervention can improve clinical outcome 
while preventing overtreatment. 
Pulmonary physicians are often confronted with the dilemma of slowly 
resolving or non-resolving pulmonary radiological infiltrates for suspected 
community-acquired pneumonia (CAP) patients started on antibiotics. Non 
resolving pneumonia is estimated to be accountable for approximately fifteen 
percentage of inpatient admissions in the department of pulmonary medicine 
and eight percentage of bronchoscopies performed.6 Slow resolution or non-
resolution of pneumonia may in turn reflect inadequate antibiotic therapy, 
impaired defence of the host, resistance to antibiotics, or extremely virulent 
organisms, nonbacterial causes, endo-bronchial lesions which causes 
obstruction in the tracheo-bronchial tree (including neoplasms), and a series of 
non-infectious causes. Around 20 percentage of non-resolving pneumonia is 
due to non-infectious causes.7 
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Despite the frequency of non-resolving pneumonia there is very little 
studies/literature addressing this issue. Hence a better understanding of non-
resolving pneumonia is the need of the hour for efficient management of this 
subset of patients. 
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REVIEW OF LITERATURE 
The terms slowly resolving pneumonia and non-resolving pneumonia 
are used interchangeably to refer to radiological abnormalities that are 
persistent beyond the expected period of time. The expected time period for 
resolution and the definition for non-resolving or slow resolving pneumonia 
however, is variably defined by many investigators.  
As defined by Hendin9 in 1975, “Slow/Non resolving pneumonia is 
persisting pulmonary consolidation more than 21 days.” 
As defined by Fein et al 10 in 1987, “Non-resolving/slow resolving 
pneumonia is a clinical condition wherein focal radiological infiltrates clearly 
begin with some clinical association of acute pulmonary infection such as 
fever, expectoration, malaise and dyspnea and fail to resolve in the expected 
period of time.” The expected period of time for radiological resolution is in 
turn influenced by both the causative pathogen and the host factors. 
Kirtland and Winterbauer11 in 1991 defined slow/non-resolving 
pneumonia in immunocompetent patients based on radiological criteria. “It is 
defined as less than 50 percentage radiological resolution by 2 weeks or less 
than complete clearing by 4 weeks.” 
Fein and Feinsilver,12 13 14 15 later modified the non/slowly resolving 
pneumonia definition i.e. with an antibiotic therapy of minimum 10 days, the 
radiological infiltrates has not resolved in an expected time frame based on the 
presumed diagnosis. 
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The above criteria usually lack precision and are arbitrary. So, many 
questions usually arise regarding non/slowly resolving pneumonia. 
What is the expected time frame for resolution? How long the treating 
doctor should wait for regression of radiological abnormalities before 
subjecting the patient to an exhaustive and expensive diagnostic work-up?  
A majority of patients with community acquired pneumonia with typical 
features of cough with sputum production, fever and radiological infiltrates 
usually resolve with proper antibiotic therapy and an aggressive diagnostic 
workup is rarely needed. 
But in a minority of patients, there is delay in radiological resolution 
which depends on lot of factors.16 17 18 These include: 
AGE: 
Among patients, who are younger than 50 years of age, 90 percentage of 
them show radiological resolution by four weeks, whereas in patients over 50 
years of age, it is only 30 percentage by four weeks even in the absence of 
associated co morbidities /medical illness.14 15 
A study done by Jose Wellington Alves Dos Santos, et al19 wherein 
pneumonia patients with non-infectious causes/infection with unusual pathogen 
that do not respond to usual antimicrobial treatment were evaluated. The 
average age was found to be 35.7 years and the range being 14-88 years.  
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In another study done by Zheng Wang, et al20 in 232 cases of non-
responding pneumonia, the average age of the population was 46 +/- 20 years. 
A study done by B Jayaprakash, et al21 to study the etiology and clinical 
outcome of non-resolving pneumonia, 84.6% patients were above the age of 40 
years. Commonly affected age group was 51-60 years. Patients aged 50 years 
and more constituted 64.3% of the total study population. 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 overall mean age of the 
patients was 51.33 ± 1.71 years (mean + SEM), and most of the patients (81%) 
were above the age of 40 years. 
In another study done by Vipparthi Surya kumari, et al23 Clinical and 
Etiological Profile of Unresolving Pneumonia Cases, the age group of the 
patients ranged from 14 – 73 years with a mean age of 48.3 ± 17.65 years. 
A study done by Jain, et al24 Role of fiber optic bronchoscopy and CT 
guided FNAC in diagnostic evaluation of Non-resolving Pneumonia involving 
sixty Five patients the mean age was 51 years. 
CO MORBIDITIES : 
With the presence of co morbidities  there is usually delay in the 
resolution of pneumonia. 
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Table 1: Co morbidities  Associated With Non/Slow Resolving Pneumonia 
CONDITION EFFECTS 
COPD Cough Impairment and Defective Mucociliary Clearance 
Alcoholism Aspiration, Malnutrition, Neutrophil Function Impairment 
Diabetes Mellitus Impaired CMI (Cell Mediated Immunity) and Impaired Function of Neutrophils 
CKD 
Impaired Function of Macrophage and Neutrophil, 
Impaired Humoral Immunity, 
Hypocomplimentemia 
Malignancy Impaired Immunity, Chemotherapy Effects 
Heart Failure Pulmonary edema, Lymphatic Drainage Impairment 
Neurological Illness Aspiration, Defective Clearance of Secretions, Defective Cough 
HIV Impairment of Both Cell Mediated and Humoral Immunity 
 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia cases, Diabetes mellitus (23.3%) was the 
most common co morbidity followed by, Chronic Obstructive Pulmonary 
Disease (20%), and Hypertension (16.6%). 
Another study done by Jain, et al24 Diagnostic evaluation of Non-
resolving Pneumonia: Bronchoscopy and CT guided FNAC in 65 patients, the 
co morbidities  associated with non-resolving pneumonia was Smoking in 25 
patients (38.4%) which is statistically significant with a P-value of 0.039, 
Diabetes mellitus in 20 patients (30.7%) which is statistically significant with a 
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P-value of 0.01, Bronchiectasis in 16 patients  (24.6%) which is statistically 
significant with a P-value of 0.045, Alcoholism in 17 patients (26.1%) which is 
statistically significant with a P-value of 0.044 and Hypertension in 12 patients 
(18.4%) with a P-value of 0.48. Diabetes had a significant correlation with 
infectious etiology than carcinoma (P value 0.01). Alcoholism had a significant 
correlation with infectious etiology than carcinoma (P value 0.044). 
Hypertension had no significant association with carcinoma or any other 
etiology (P value 0.48). 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, Diabetes 
mellitus was the commonest co morbidity and was noted in 20 patients 
(33.33%). Diabetes was significantly more associated with infective etiology, 
compared to malignancy (P = 0.023). Klebsiella pneumoniae was the most 
common organism isolated in patients with diabetes mellitus, in 6 out of 20 
diabetics (30%), followed by Mycobacterium tuberculosis in 5 patients (25%) 
and Staphylococcus aureus in 4 patients (20%).  
A study done by B Jayaprakash, et al21  to study the etiology and clinical 
outcome of non-resolving pneumonia in 70 patients, Smoking was the most 
common co morbidity in 42 patients (60%) with a P-value of  <0.05 followed 
by Alcohol abuse in 34 patients (48.6%) with a P-value of <0.05, Chronic 
Obstructive Pulmonary Disease in 25 patients (35.7%) with a P-value of 
<0.001, Hypertension in 15 patients (21.4%) with a P-value of  <0.001, 
Diabetes in 32 patients (45.7%) with a P-value of <0.01, CAD in 13 patients 
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(18.6%) with a P-value of <0.001 and Immunosuppression in 5 patients (7.1%) 
with a P-value of <0.01. Smoking in 42 patients (60%) was the most common 
co morbidity noted. Alcohol abuse in 34 patients (48.6%), diabetes mellitus in 
32 patients (45.7%), COPD in 25 patients (35.7%) and hypertension in 15 
patients (21.4%) were the other statistically significant co morbidities. 
SEVERITY: 
When comparing mild to moderate with severe pneumonia the estimated 
time period of resolution is 3-4 weeks and 10 weeks respectively. 
INFECTIOUS AGENT: 
The rate at which clinical and radiological improvement occurs usually 
varies with the microorganism/infectious agent that is causing the pneumonia.10 
Table: 2 Radiological Resolution Among Different Infectious Agent 
Infectious agent Frequency of 
Transient 
radiological 
resolution 
Time taken for 
full 
Radiological 
resolution 
Prevalence of 
Residual 
radiological 
abnormalities 
Staphylococcus 
Aureus 
In A Majority Of 
Patients 
3-5 Months Common 
Streptococcus 
Pneumoniae 
(Non-Bacteremic) 
Occasional 1-3 Months Rare 
Streptococcus 
PneumoniaeWith 
Sepsis 
In A Majority Of 
Patients 
3-5 Months 25-35 Percentage 
Legionella In A Majority Of 
Patients 
2-6 Months 25 Percentage 
Gram Negative 
Bacteria 
Occasional 3-5 Months 10-20 Percentage 
HemophilusInfluenzae Occasional 1-5 Months Occasional 
Mycoplasma 
Pneumoniae 
Rare 2-4 Weeks Rare 
Chlamydia Species Rare 1-3 Months 10-20 Percentage 
Moraxella Catarrhalis Rare 1-3 Months Unusual 
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MISDIAGNOSIS OF PATHOGENS: 
Whenever there is failure of resolution to treatment with antibiotic 
therapy, one should consider the possibility of infection with alternative 
pathogenic microorganisms. These pathogenic microorganisms of concern 
include mycobacteria include Mycobacterium tuberculosis and NTM (non-
tuberculous mycobacteria), Nocardia, Actinomyces and fungal pneumonia. 
TUBERCULOSIS — Tuberculosis is of significant concern, because the 
way it presents as non-resolving pneumonia is atypical and it affects the elderly 
people with co morbidity, especially in diabetics and radiological areas 
involved  are usually the mid and lower lung zones. Making a diagnosis in such 
cases is usually difficult because of the low sputum production and when 
mycobacterium tuberculosis culture is done it usually takes time before the 
result is available. Polymerase chain reaction (PCR) and gene xpert with 
sputum/bronchial wash specimens are useful in diagnosing tuberculosis. 
FUNGI — Another pathogenic organism which can closely mimic bacterial 
pneumonia is fungi, which may be either opportunistic or endemic fungi. In 
patients presenting with non-resolving pneumonia one such fungi of particular 
concern is aspergillus, which can present as chronic necrotizing aspergillosis or 
invasive aspergillosis.  
Patients with later stage of acquired immune deficiency syndrome 
(AIDS) are at higher risk of developing invasive aspergillosis. 
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Although invasive aspergillosis is classically seen in neutropenic patients, who 
are put on multiple antibiotics over a period of several days, it is on the rise and 
it is increasingly diagnosed in elderly patients particularly with chronic lung 
disease who are being put on long term corticosteroids. In this setting, 
aspergillus usually mimics a bacterial pneumonia, and one classic case series 
demonstrated that before the diagnosis of invasive aspergillosis was made, 
patients were treated with multiple antibiotics over an average period of 18 
days.25 Endemic fungal infections should be considered as a cause of non-
resolving pneumonia when a patients present from an endemic area. The 
diagnosis include coccidioidomycosis, histoplasmosis, cryptococcosis and 
blastomycosis.26 
NOCARDIA AND ACTINOMYCES —Though Actinomyces and Nocardia 
belong to higher order bacteria, infection by these organisms usually have a 
clinical presentation similar to that of a fungal etiology. Infection with 
Nocardia usually presents as a homogenous alveolar infiltrate which is 
localized, cavitary and non-segmental. Infection with Actinomyces usually has 
a similar appearance but has the capability to cross fissures and invade the 
chest wall. 
RESISTANT BACTERIAL PATHOGENS: 
Whenever there is delay in the resolution of pneumonia/no appropriate 
response to the antibiotic therapy one should consider the possibility of 
infection with a resistant pathogen. Although Pneumococcus (streptococcus 
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pneumoniae) which is resistant to penicillin is of most concern, other multidrug 
resistant organisms such as Pseudomonas aeruginosa, Haemophilus influenzae 
and MRSA (Methicillin Resistant Staphylococcus Aureus) are being 
recognized increasingly as causes of non-resolving pneumonia in the 
community. 
DEVELOPMENT OF COMPLICATIONS FROM THE INITIAL 
PNEUMONIA: 
When there is a focus of infection which is sequestrated it may prevent 
the antibiotics from reaching the infection site. Classical examples where there 
is sequestrated focus of infection which results in poor antibiotic penetration 
into the infectious site and delays the resolution of pneumonia are lung abscess 
and empyema. 
NON-INFECTIOUS ETIOLOGIES: 
Around 20 percentage of patients presenting with community acquired 
pneumonia that is non-responding is due to non-infectious causes. A wide 
range of non-infectious etiology can cause a pulmonary infiltrate, which can 
present as pneumonia, which is non-resolving. These include the below 
categories namely 
 Neoplastic, 
 Inflammatory, 
 Drug induced and 
 Vascular Disease 
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Table: 3 Non Infectious Etiologies Associated With Non/Slow  
Resolving Pneumonia 
MALIGNANCIES 
Bronchogenic carcinoma 
Bronchoalveolar cell carcinoma27 
Lymphoma28 
IMMUNOLOGIC CONDITIONS 
BOOP (Bronchiolitis obliterans organizing pneumonia) 
Vasculitis 
Wegners granulomatosis (granulomatosis with polyangitis) 
Diffuse alveolar haemorrhage 
Sarcoidosis 
Systemic lupus erythematosus 
Acute interstitial pneumonia29 30 
Eosinophilic pneumonias31 32 33 
               Acute eosinophilic pneumonia 
               Chronic eosinophilic pneumonia 
Pulmonary alveolar proteinosis34 
DRUG INDUCED/TOXICITY35 
PULMONARY VASCULAR ABNORMALITIES 
Heart failure 
Pulmonary embolism 
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There are only a few studies on non-resolving pneumonia which 
evaluated the various aspects of it and the factors associated with it and its 
etiology. 
SEX DISTRIBUTION IN NON-RESOLVING PNEUMONIA: 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia Cases, The incidence of Non-resolving 
pneumonia was more common in males (68.3%), when compared to females 
(33.3%). 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, 41 (68.3%) 
were males and 19 (31.7%) were females. 
A study done by Jain, et al24 Diagnostic evaluation of Non-resolving 
Pneumonia: Bronchoscopy and CT guided FNAC in Sixty Five patients the 
male:female ratio was 1:2.8 with 48 males (73.8%) and 17 females (26.1%). 
A study done by B Jayaprakash, et al21 to study the etiology and clinical 
outcome of non-resolving pneumonia in 70 patients, males were 48 (68.6%) 
and females were 22 (31.4%) with a male: female ratio 2.18:1 
In another study done by Jose Wellington Alves Dos Santos, et al19 16 
pneumonia patients with noninfectious causes/infection with unusual pathogen 
that do not respond to usual antimicrobial treatment were evaluated. Out of 16 
patients 9 (56%) were males, and 7 (44%) were females. 
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SYMPTOMS IN NON-RESOLVING PNEUMONIA: 
A study done by B Jayaprakash, et al21 to study the etiology and clinical 
outcome of non-resolving pneumonia in 70 patients, Cough (87.1%) and Fever 
(80%) were the most common symptoms. 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, the most 
common symptoms were cough (100%), followed by fever (96%), hemoptysis 
(53%), chest pain (38%), and breathlessness (33%). 
A study done by Jain, et al24 Diagnostic evaluation of Non-resolving 
Pneumonia: Bronchoscopy and CT guided FNAC in Sixty Five patients, the 
most common symptoms were Cough in 62 patients (95%), Fever in 55 
patients (84.6%), Hemoptysis in 30 patients (46%), Chest pain in 28 patients 
(43%) and Shortness of breath in 20 patients (30.7%). 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia cases, the most common presenting 
symptoms were cough (100%) followed by dyspnea (70%), fever (56.6%), 
chest pain (30%) and hemoptysis (10%). 
In another study done by Jose Wellington Alves Dos Santos, et al19 16 
pneumonia patients with non-infectious causes/infection with unusual pathogen 
that do not respond to usual antimicrobial treatment were evaluated. The most 
common symptoms were cough (100%), fever (100%), and shortness of breath 
(69%). Out of the patients having cough as a symptom dry cough was present 
in 56.25% patients and productive cough in 43.75% patients. 
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LOBES INVOLVED IN NON RESOLVING PNEUMONIA: 
Jain, et al24 Diagnostic evaluation of Non-resolving Pneumonia: 
Bronchoscopy and CT guided FNAC in 65 patients, the lobes involved were 
Right upper lobe in 23 patients (35%), Right lower lobe in 14 patients (21%), 
Left upper Lobe in 12 patients (18%), Multi lobar involvement in 8 patients 
(12.3%), Left lower Lobe in 6 patients (9.2%) and Right middle lobe in 2 
patients (3%). 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia cases, Lobar pneumonia was seen in 80% of 
patients, bronchopneumonia in 20% of patients. Right lung lesions were found 
in 60% of patients, left lung in 36.6% patients and bilateral involvement was 
seen in 3.3% patients. 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, Right lung 
was involved in 39 (65%) patients, and Left Lung in 21 (35%) patients. The 
most commonly involved lobe was right upper lobe (25%), followed by right 
lower lobe (23%), left lower lobe (21%), and left upper lobe (15%). Bilateral 
and multilobar involvement were seen in 10 (16.67%) patients and were more 
common in tuberculosis and staphylococcal pneumonia (P = 0.0007). 
A study done by B Jayaprakash, et al21 to study the etiology and clinical 
outcome of non-resolving pneumonia in 70 patients, unilateral lung 
involvement was seen in 82.9% patients, with radiological lower zone 
involvement in 65.7%. 
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In another study done by Jose Wellington Alves Dos Santos,et al19 16 
pneumonia patients with noninfectious causes/infection with unusual pathogen 
that do not respond to usual antimicrobial treatment were evaluated. The lobes 
involved were left upper lobe in 4 patients, bilateral involvement in 4 patients, 
lingular involvement in 3 patients, right lower lobe in 2 patients, left lower lobe 
in 2 patients and right upper lobe in 1 patient.  
 
SMOKING AND NON-RESOLVING PNEUMONIA: 
Jain, et al24 Diagnostic evaluation of Non-resolving Pneumonia: 
Bronchoscopy and CT guided FNAC in 65 patients, Smoking was found to 
have a more significant association with malignancy than infectious etiology 
group (p value 0.039). 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia cases, Smoking was the most common risk 
factor associated with Non-resolving pneumonia (66.6%) 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, 25 patients 
(41.6%) were smokers, and smoking was found to have a more distinct 
association with malignancy, compared to other  etiological groups (P = 0.006). 
The most common co morbidity noted was smoking in 42 patients (60%).Out 
of the smokers 40% had a smoking index above 500. 
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ETIOLOGY OF NON-RESOLVING PNEUMONIA: 
A study done by Jose Wellington Alves Dos Santos, et al19 wherein 180 
patients admitted with community acquired pneumonia, 16 patients with 
noninfectious causes/infection with unusual pathogen that do not respond to 
usual antimicrobial treatment were evaluated. The Non-infectious etiology was 
Pulmonary embolism with pulmonary infarction in 2 cases, Wegner’s 
granulomatosis, Bronchocentric granulomatosis, Hypersensitivity pneumonitis, 
Cryptogenic organizing pneumonia, Acute leukemia with pulmonary infarction 
and Pulmonary metastasis of gastric carcinoma in 1 patient each. Coming to the 
infection with unusual pathogenic organism the etiology diagnosed was 
Tuberculosis and Cryptococcosis in 2 patients each, Actinomycosis, 
Paracoccidioidomycosis and histoplasmosis in 1 patient each. 
A study done by B Jayaprakash, et al21 to study the etiology and clinical 
outcome of non-resolving pneumonia in 70 patients, the etiology was 
Tuberculosis in 11 patients (15.71%), Probable tuberculosis in 14 patients 
(20%), Malignancy in19 patients (27.1%), Bronchiectasis in 6 patients (8.6%), 
PCP in 5 patients (7.1%), BOOP in 4 patients (5.7%) ,Resistance to empirical 
antibiotics in 10 patients (14.3%) and others in 1 patient (1.4%). 
A study on non-resolving pneumonia with special reference to role of 
fiber optic bronchoscopy done by Chaudhuri, et al22 in 60 patients, the etiology 
diagnosed was Bacterial pneumonia in 32 patients (53.33%), Bronchogenic 
carcinoma in 16 patients (26.67%), Tuberculosis in 10 patients (16.67%), 
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Wegener’s granulomatosis in 1 patient (1.67%) and Undiagnosed in 1 patient 
(1.67%). 
In another study by Jain, et al24 Diagnostic evaluation of Non-resolving 
Pneumonia: Bronchoscopy and CT guided FNAC in 65 patients, the etiology 
was Pyogenic infection in 24 patients (37%), Pulmonary tuberculosis in 19 
patients (29.2%), Bronchogenic carcinoma in 15 patients (23%), Foreign body 
in 2 patients (3%), Segmental bronchial stenosis in 1 patient (3%), Multiple 
blood clots in 1 patient (1.5%), Wegners granulomatosis in 1 patient (1.5%) 
and Undiagnosed in 2 patients (3%). 
A study done by Vipparthi Surya kumari, et al23 Clinical and Etiological 
Profile of Unresolving Pneumonia cases, etiology diagnosed were Tuberculosis 
in 10 patients (33.3%), Malignancy in 9 patients (30.3%), Bacterial pneumonia 
unresponsive to empirical antibiotics in 5 patients (16.6%), Occult 
bronchiectasis in 2 patients (6.6%), Cryptogenic organizing pneumonia in 1 
patient (3%), Pulmonary infarction in 1 patient (3%) and undiagnosed in 2 
cases (6.6%). 
With the above literature, our study was taken primarily to analyze the 
factors such as sociodemographic, clinico-radiological, microbio-pathological 
profile and etiology of non-resolving pneumonia and the usefulness of 
bronchoscopy and bronchial wash gene xpert. 
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AIMS AND OBJECTIVES 
PRIMARY OBJECTIVES: 
 To study the  
SOCIODEMOGRAPHIC PROFILE 
CLINICO-RADIOLOGICAL PROFILE 
MICROBIO-PATHOLOGICAL ETIOLOGY 
of patients admitted with Non-resolving pneumonia in a Tertiary care 
hospital. 
SECONDARY OBJECTIVES 
 To study the co-morbidities associated with non-resolving pneumonia. 
 To study the usefulness/diagnostic yield of bronchoscopy in non-
resolving pneumonia. 
 To study the usefulness of Bronchial wash gene-xpert in diagnosing 
tuberculosis in non-resolving pneumonia. 
 To compare Bronchial wash gene-xpert Vs. Bronchial wash AFB (Acid 
Fast Bacilli) smear in diagnosing tuberculosis in non-resolving 
pneumonia. 
 To compare Bronchial wash gene-xpert Vs. Post bronchoscopy sputum 
AFB smear in diagnosing tuberculosis in non-resolving pneumonia. 
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MATERIALS AND METHODS 
SUBJECT SELECTION: 
Patients admitted in Rajiv Gandhi Government General Hospital, with 
non-resolving pneumonia who meets the case definition as given below were 
selected. 
“Non-resolving pneumonia is defined as a clinical condition wherein 
there is radiological infiltrates (focal or diffuse, unilateral or bilateral, 
parenchymal or interstitial) begin with clinical association of acute 
pulmonary infection and with a minimum 10 days of standard 
antimicrobial therapy, patients either fail to improve or worsen, or 
radiological opacities fail to resolve by 50% at 2 weeks or less than 
complete clearing at 4 weeks.”10, 11, 12, 13, 14, 15, 21, 22 
INCLUSION CRITERIA: 
 Patients admitted in department of thoracic medicine of both genders, 
diagnosed as cases of non-resolving pneumonia. 
 Patients referred from other departments, diagnosed as cases of non-
resolving pneumonia. 
EXCLUSION CRITERIA: 
 Patients already diagnosed as  
 Sputum positive tuberculosis 
 Lung cancer 
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 Hospital acquired (HAP) and Ventilator associated (VAP) 
pneumonia 
 Patients having very poor general condition, very severe breathlessness, 
recent history of myocardial infarction and patients not fit for 
bronchoscopy. 
 Patients not willing to give informed written consent. 
STUDY CENTRE: 
The study was conducted in Rajiv Gandhi Government General 
Hospital, Park Town, Chennai, which is a tertiary care institute. 
 
STUDY DESIGN: 
 The study was a prospective observational study. 
 Consecutive patients admitted with the diagnosis of Non-resolving 
pneumonia during the study period were included in the study. 
 No specific method of randomization was used. 
 No controls were used in the study. 
 
STUDY PERIOD: 
8 months, February 2015 – September 2015 
 
METHODOLOGY: 
A total of 420 patients were admitted with provisional diagnosis of 
pneumonia during the study period. Out of them, 55 patients (13%) who met 
 22 
 
the case definition of non-resolving pneumonia, satisfying the inclusion and 
exclusion criteria and gave informed consent to participate were enrolled in the 
study. 
1. Socio-demographic data of the patients such as 
 Age 
 Gender 
 Education of the patient and head of the household 
 Occupation of the patient and head of the household 
 Gross total income of the patient’s family 
was collected. 
2. Detailed clinical history of the patients was collected. The clinical 
history included  
 The presenting complaint/symptom for which the patient came to the 
hospital and the duration of the complaint/symptom and a detailed 
history of presenting illness. 
 The past history of the patient, whether he had any history of 
previous similar illness/any respiratory illness. 
 The treatment history, family history and occupational history. 
 The personal history of the patient including history of smoking and 
history of alcohol intake.  
 If smoking history is present it was quantified and the severity 
graded with smoking index.36 Severity of smoking has traditionally 
been measured as smoking pack years. However it has not been 
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validated for quantifying other forms of tobacco use like bidis. 
Besides, the number of cigarettes in a pack varies indifferent brands. 
Since a considerable fraction of our study population used bidis, we 
used the tool Smoking Index instead of smoking pack years to 
quantify smoking. 
Smoking index is calculated as the product of number of cigarettes 
or bidis smoked per day and the duration of smoking habit in years.  
Table 4: Severity of smoking based on Smoking Index 
SMOKING INDEX SEVERITY OF SMOKING 
< 100 Light smokers 
100 – 300 Moderate smokers 
> 300 Heavy smokers 
 
Thus smoking index takes into account both the quantity and the 
chronic nature of the problem. 
A person was considered to be a non-smoker if he or she has smoked 
less than 100 cigarettes or bidis in his/her lifetime. 
 History of any Co morbidities  such as 
 Diabetes mellitus 
 Chronic obstructive pulmonary disease (COPD) 
 Bronchial Asthma 
 Chronic kidney disease (CKD)/Renal Failure 
 Malignancy 
 Heart failure/Coronary artery disease 
 Hypertension 
 Neurological illness 
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3.  General examination and a structured clinical examination of respiratory 
system and other systems were done. 
4.  Basic blood investigations of  
 Complete Blood Count 
 Renal Function Test  
 Liver Function Tests were done in all patients. 
5.  Chest skiagram (postero-anterior and lateral view) was taken at the time 
of inclusion into the study. 
Plain Computed Tomography(CT) chest (OR) Contrast enhanced CT 
chest (CECT)  (OR)  High Resolution Computed Tomography chest 
(HRCT) as demanded by the case scenario were done. 
6.  Other relevant investigations, necessary for diagnosis were done. 
7.  A careful pre-evaluation and cardiac fitness which includes an echo was 
done prior to Fiber optic bronchoscopy (FOB) in all patients. 
8.  As per BTS indication Fiber optic bronchoscopy (FOB) was done in all 
patients. Bronchoscopy (FOB) was done as per British Thoracic Society 
guideline for diagnostic flexible bronchoscopy in adults using Olympus 
fiber optic bronchoscope and strict disinfection protocol was followed 
for disinfecting the bronchoscope pre and post bronchoscopy as per the 
above mentioned guidelines.37 38 
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9.  Bronchial washing from the involved lobe and the segment affected was 
done and the specimen obtained was sent for 
 Gene xpert39 (CB-NAAT=cartridge based nucleic acid 
amplification test) which was being done at State Intermediate 
Reference Laboratory (IRL), Chetpet, Chennai. 
 AFB smear (Acid Fast Bacilli smear) 
 Non tuberculous bacterial culture 
 Cytology 
 Cell count 
 Fungal smear 
10. During FOB 
 Endo bronchial biopsy 
 Trans bronchial lung biopsy if necessary were done. 
11. Early morning samples were sent on first and second day post 
bronchoscopy for AFB smear examination.40 
12. One early morning sputum sample was sent on first day Post 
  bronchoscopy for cytology.41 
13. CT guided biopsy if necessary was done in diagnosing the cause for  
   non-resolving pneumonia. 
14. The cause for Non-Resolving Pneumonia was diagnosed and the 
   patient treated accordingly. 
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STATISTICAL ANALYSIS: 
Statistical analysis was done using the SPSS software. Significance of 
correlation between variables was assessed using P value. A correlation was 
considered to be statistically significant if its P value is less than 0.05.  
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AGE DISTRIBUTION: 
 
A total number of 55 patients who satisfied the inclusion and exclusion 
criteria were included in our study. The mean age of the total 55 patients was 
49.3 years with a standard deviation of 12.5. The age of the patients ranged 
from 20 years-69 years. The percentage of the patients belonging to the 5 age 
groups namely  <30 years, 31-40 years, 41-50 years, 51-60 years and  >60 
years were 10.9%,  10.9%,  23.6%,  38.2%  and  16.4% respectively. 
 
Fig 1: Age Distribution 
AGE DISTRIBUTION  (49.3 +/- 12.5) 
  Freq. % 
< 30 years 6 10.9 
31 to 40 years 6 10.9 
41 to 50 years 13 23.6 
51 to 60 years 21 38.2 
> 60 years 9 16.4 
Total 55 100 
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GENDER DISTRIBUTION: 
Out of the total 55 patients, 44 patients were males and 11 patients were 
females. Thus males accounted for 80% of our study population while females 
accounted for 20%. 
GENDER DISTRIBUTION 
  Freq. % 
Female 11 20.0 
Male 44 80.0 
Total 55 100.0 
 
 
 
Fig 2: Gender Distribution 
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PATIENT’S EDUCATIONAL STATUS: 
In our study, out of 55 patients 49.1% were illiterate and 18.2% 
completed primary school, 10.9% completed middle school, 7.3% completed 
high school, 9.1% completed higher secondary school, 1.8% completed 
diploma and 3.6% completed post graduate diploma. 
PATIENT’S EDUCATIONAL STATUS 
  Freq. % 
Illiterate 27 49.1 
Primary School 10 18.2 
Middle School 6 10.9 
High School 4 7.3 
Higher Sec. School 5 9.1 
Diploma 1 1.8 
Post Graduate Diploma 2 3.6 
Total 55 100.0 
 
Fig 3: Educational Status 
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GROSS TOTAL INCOME PER DAY: 
The gross total income per day of the family in our study was less than 
or equal to 250 Rupees in 28 patients, 251-500 Rupees in 18 patients and 501-
1000 Rupees in 9 patients. 
GROSS TOTAL INCOME PER DAY 
  Freq. % 
≤ 250 28 50.9 
251 TO 500 18 32.7 
501 TO 1000 9 16.4 
Total 55 100.0 
 
 
Fig 4: Gross Total Income Per Day 
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PRESENTING SYMPTOMS: 
The presenting symptom of the patients in our study was cough with 
expectoration in 54.5% of patients, dyspnea in 16.4%, hemoptysis in 10.9%, 
chest pain in 7.3%, dry cough in 5.5% and fever in 5.5%. 
SYMPTOMS 
  Freq. % 
DRY COUGH 3 5.5 
COUGH WITH EXPECTORATION 30 54.5 
DYSPNEA 9 16.4 
CHEST PAIN 4 7.3 
HEMOPTYSIS 6 10.9 
FEVER 3 5.5 
Total 55 100.0 
 
 
Fig 5: Presenting Symptoms 
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DURATION OF SYMPTOMS: 
The duration of symptoms in our study were divided into 3 groups 
namely 4-6 weeks, 6-8 weeks and >8 weeks. 22 of our patients had a symptom 
duration of >8 weeks, 21 patients had a symptom duration of 4-6 weeks and 12 
patients had a symptom duration of 6-8 weeks. 
DURATION OF SYMPTOMS 
  Freq. % 
4-6 WEEKS 21 38.2 
6-8 WEEKS 12 21.8 
>8 WEEKS 22 40.0 
Total 55 100.0 
 
 
Fig 6: Duration of Symptoms 
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PAST HISTORY OF RESPIRATORY ILLNESS: 
Among 55 patients in our study 65.5% patients had no prior respiratory 
illness and 34.5% had a past history of respiratory illness. 
PAST HISTORY OF RESPIRATORY ILLNESS 
  Freq. % 
NO 36 65.5 
YES 19 34.5 
Total 55 100.0 
 
 
 
 
Fig 7: Past History of Respiratory Illness 
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SMOKING STATUS OF STUDY POPULATION: 
Out of 55 patients in our study, 47.3% were smokers, 52.7% were non-
smokers. None of the female patients were smokers. 
SMOKER 
  Freq. % 
NO 29 52.7 
YES 26 47.3 
Total 55 100.0 
 
 
Fig 8: Smoking Status of Study Population 
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SEVERITY/QUANTIFICATION OF SMOKING: 
Out of the smokers, 31% were moderate smokers, 69% were heavy smokers. 
SEVERITY/QUANTIFICATION OF SMOKING 
  Freq. % 
MODERATE SMOKER (101 to 300) 8 31 
HEAVY SMOKER (>300) 18 69 
Total 26 100 
 
Fig 9: Severity/Quantification of Smoking 
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HISTORY OF ALCOHOL CONSUMPTION: 
Out of 55 patients in our study, 54.5% patients had a history of chronic 
alcohol intake. 45.5% patients were non-alcoholics. None of the female 
patients in our study were alcoholics. 
HISTORY OF ALCOHOL CONSUMPTION 
  Freq. % 
NO 25 45.5 
YES 30 54.5 
Total 55 100 
 
 
Fig 10: History of Alcohol Consumption 
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CO MORBIDITIES : 
Out of the 55 patients in our study, 45 patients had a history of  
co morbid disease. 10 patients had no history of any co morbidities. 
CO MORBIDITIES  
  Freq. % 
NO 10 18.2 
YES 45 81.8 
Total 55 100.0 
 
Among the patients with co morbidities , diabetes was present in 40%, 
COPD in 22.22%, renal failure in 6.67%, anaemia in 6.67%, bronchial asthma 
in 4.44% and other co morbidities  in 20%. 
 
Fig 11.2: Co Morbidities  
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AUSCULTATORY FINDING: 
Of the total 55 patients in our study, crackles was the most common 
auscultatory finding in 80%, wheeze in 14.5% and diminished breath sounds in 
5.5%. 
AUSCULTATORY FINDING 
  Freq. % 
CRACKLES 44 80.0 
DIMINISHED BREATH SOUND 3 5.5 
WHEEZE 8 14.5 
Total 55 100.0 
 
Fig 12: Auscultatory Finding 
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LOBES INVOLVED: 
In our study the lobes involved in the patients were assessed using a 
Computed Tomography chest. Left upper lobe involvement was seen in 25.4%, 
right upper lobe in 21.8%, diffuse involvement again in 21.8%, left lower lobe 
in 12.7%, right lower lobe in 10.9%, and right middle lobe in 7.3%. 
LOBES INVOLVED(CT-CHEST) 
  Freq. % 
LEFT LOWER LOBE 7 12.7 
LEFT UPPER LOBE 13 25.4 
RIGHT LOWER LOBE 6 10.9 
RIGHT MIDDLE LOBE 4 7.3 
RIGHT UPPER LOBE 12 21.8 
DIFFUSE INVOLVEMENT 12 21.8 
Total 55 100.0 
 
Fig 13: Lobes Involved (CT-Chest) 
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BRONCHOSCOPY FINDINGS: 
Out of 55 patients in our study the most common bronchoscopic finding 
was purulent secretions in 43.6%, mucosal inflammation in 38.2%, 
intraluminal mass/granulation tissue in 9.1%, blood stained secretions in 5.5 
and mucous plugging in 3.6%.  
BRONCHOSCOPY FINDINGS 
  Freq. % 
BLOOD STAINED SECRETIONS 3 5.5 
INTRALUMINAL GRANULATION TISSUE/MASS 5 9.1 
MUCOSAL INFLAMMATION 21 38.2 
MUCOUS PLUGGING 2 3.6 
PURULENT SECRETIONS 24 43.6 
Total 55 100.0 
 
 
Fig 14: Bronchoscopy Findings 
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BRONCHIAL WASH GENE XPERT: 
Out of 55 patients in our study, Bronchial wash Gene Xpert had a result 
of MTB DETECTED in 41.8% and MTB NOT DETECTED in 58.2%. 
BRONCHIAL WASH GENE-XPERT 
  Freq. % 
MTB NOT DETECTED 32 58.2 
MTB DETECTED 23 41.8 
Total 55 100.0 
 
 
Fig 15: Bronchial Wash Gene Xpert 
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GENE XPERT RIFAMPICIN RESISTANCE: 
Out of 23 patients in whom MTB DETECTED all 23 patients had a 
result of RIFAMPICIN RESISTANCE-NOT DETECTED. No patient had a 
result of RIFAMPICIN RESISTANCE- DETECTED. 
GENE XPERT RIFAMPICIN RESISTANCE 
  Freq. % 
NOT DETECTED 23 100.0 
DETECTED 0 0 
Total 23 100.0 
 
 
Fig 16: Gene Xpert Rifampicin Resistance 
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BRONCHIAL WASH AFB SMEAR: 
Out of 55 patients in our study Bronchial wash AFB smear was positive 
in 21.8% and negative in 78.2%. 
BRONCHIAL WASH AFB SMEAR 
  Freq. % 
NEGATIVE 43 78.2 
POSITIVE 12 21.8 
Total 55 100.0 
 
 
Fig 17: Bronchial Wash AFB Smear 
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BRONCHIAL WASH BACTERIAL CULTURE: 
Out of the total 55 patients in our study, Bronchial wash BACTERIAL 
CULTURE was contributory in arriving at a diagnosis in 14.5% of patients. 
BRONCHIAL WASH BACTERIAL CULTURE 
  Freq. % 
NOT CONTRIBUTORY 47 85.5 
CONTRIBUTORY TO DIAGNOSIS 8 14.5 
Total 55 100.0 
 
 
Fig 18: Bronchial Wash Bacterial Culture 
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BRONCHIAL WASH CULTURE RESULTS: 
Bronchial wash culture results that are contributory to the diagnosis are 
attached below. 
Table 5: Bronchial Wash Culture Results 
BRONCHIAL WASH CULTURE RESULTS 
  Freq. 
ACINETOBACTER 1 
E.COLI 1 
KLEBSIELLA PNEUMONIAE 1 
NOCARDIA SPECIES 1 
PSEUDOMONAS AERUGINOSA 1 
PROTEUS MIRABILIS  1 
PROTEUS VULGARIS 1 
ACTINOMYCETES 1 
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BRONCHIAL WASH CYTOLOGY REPORTS: 
Out of the total 55 patients in our study a cytology report of acute 
inflammatory pathology was obtained in 54.5% of patients, chronic 
inflammatory pathology in 32.7% of patients and atypical cells seen(positive 
for malignancy) in 12.7% of patients. 
BRONCHIAL WASH CYTOLOGY 
  Freq. % 
ACUTE INFLAMMATORY PATHOLOGY 30 54.5 
ATYPICAL CELLS SEEN(POSITIVE FOR MALIGNANCY) 7 12.7 
CHRONIC  INFLAMMATORY PATHOLOGY 18 32.7 
Total 55 100.0 
 
 
Fig 19: Bronchial Wash Cytology 
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BRONCHIAL WASH FUNGAL SMEAR/CULTURE: 
Out of the 55 patients in our study none had a positive fungal 
smear/culture. 
ENDOBRONCHIAL BIOPSY: 
Out of the 55 patients in our study, endobronchial biopsy was done in 6 
patients and was contributory to the diagnosis in all 6 of them. 4 cases were 
diagnosed as carcinoma, 1 as carcinoid tumor and 1 as fungal pneumonia 
(mucormycosis). 
 
Fig 20: Endobronchial Biopsy 
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TRANSBRONCHIAL LUNG BIOPSY (TBLB): 
Out of the 55 patients in our study, TBLB was done in 3 patients and it 
was contributory to diagnosis in all 3 patients. 1 case was diagnosed as BOOP, 
1 as Chronic HSP (bird fanciers lung) and 1 Actinomycetes pneumonia. 
 
Fig 21: Transbronchial Lung Biopsy 
CT-GUIDED BIOPSY: 
Out of the 55 patients in our study, CT-GUIDED BIOPSY was done in 
4 patients and it was contributory to diagnosis in all 4 patients. 3 cases were 
diagnosed as carcinoma and 1 as lipoid pneumonia. 
 
Fig 22: CT-Guided Biopsy 
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POST FOB SPUTUM AFB SMEAR: 
Out of 55 patients in our study, POST FOB SPUTUM AFB SMEAR 
was done in all 55 patients and it was positive and contributory to the diagnosis 
in 4 patients. 
POST FOB SPUTUM AFB SMEAR 
  Freq. % 
POSITIVE 4 7.3 
NEGATIVE 51 92.7 
Total 55 100.0 
 
 
Fig 23: Post Fob Sputum AFB Smear 
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POST FOB SPUTUM CYTOLOGY: 
Out of the 55 patients in our study, POST FOB SPUTUM CYTOLOGY 
was done in all 55 patients and it was contributory in diagnosing the cause of 
NRP in 4 patients. 
POST FOB SPUTUM CYTOLOGY 
  Freq. % 
CONTRIBUTORY 4 7.3 
NOT CONTRIBUTORY 51 92.7 
Total 55 100.0 
 
 
Fig 24: Post Fob Sputum Cytology 
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ETIOLOGY DIAGNOSED: 
Out of the 55 patients in our study, etiology of NRP was diagnosed in 
92.7% (n=51) of patients and not diagnosed in 7.3% (n=4) of patients. 
ETIOLOGY 
  Freq. % 
YES 51 92.7 
NO 4 7.3 
Total 55 100.0 
 
Table 6: Etiology Diagnosed 
ETIOLOGY DIAGNOSED 
  
NO OF 
CASES 
TUBERCULOSIS 23 
BACTERIAL PNEUMONIA 8 
CARCINOMA 7 
ALLERGIC BRONCHOPULMONARY 
ASPERGILLOSIS(ABPA) 
2 
CHRONIC HYPERSENSITIVITY PNEUMONITIS 2 
SILICOSIS 3 
SLE PNEUMONITIS 1 
BRONCHIOLITIS OBLITERANS ORGANISING 
PNEUMONIA(BOOP) 
1 
CARCINOID TUMOR 1 
FUNGAL PNEUMONIA (MUCOR) 1 
DAH WITH PULMONARY RENAL SYNDROME 1 
LIPOID PNEUMONIA 1 
UNDIAGNOSED 4 
Total 55 
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Fig 26.1, 26.2: Etiology Diagnosed 
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AGE DISTRIBUTION IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common age group affected  was 50-60 years, followed by 
41-50 years, >60 years, <30 years and 31-40 years in that order, with a P-value 
of 0.504. 
CORRELATION BETWEEN AGE GROUP AND TUBERCULOSIS 
DIAGNOSIS 
 
TB 
Total 
Chi Square 
OTHER 
DIAGNOSIS TUBERCULOSIS P-Value 
Age 
Group 
< 30 2 4 6 
  
0.504 
  
  
  
31 to 40 5 1 6 
41 to 50 7 6 13 
51 to 60 13 8 21 
> 60 5 4 9 
Total 32 23 55 
     
Fig 27: Correlation Between Age Group And Tuberculosis Diagnosis 
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AGE DISTRIBUTION IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common age group affected  was 51-60 years, followed by 
>60 years, 41-50 years and <30 years in that order with a P-value of 0.680 
CORRELATION BETWEEN AGE GROUP AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma 
Total 
Chi 
Square 
Other 
diagnosis Carcinoma 
P-Value 
Age 
Group 
< 30 5 1 6 
  
0.680 
  
  
  
31 to 40 6 0 6 
41 to 50 12 1 13 
51 to 60 17 4 21 
> 60 7 2 9 
Total 47 8 55 
Fig 28: Correlation Between Age And Carcinoma Diagnosis 
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AGE DISTRIBUTION IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common age group affected  was 41-50 years, 
followed by >60 years, 51-60 years and 31-40 years in that order with a P-
value of 0.211 
CORRELATION BETWEEN AGE GROUP AND BACTERIAL 
PNEUMONIA 
 
Bacterial pneumonia Total 
Chi 
Square 
Other diagnosis 
Bacterial 
pneumonia P-Value 
 
 
 
Age 
Group 
< 30 6 0 6 
  
0.211  
 
  
  
31 to 40 5 1 6 
41 to 50 9 4 13 
51 to 60 20 1 21 
> 60 7 2 9 
Total 47 8 55 
 
Fig 29: Correlation Between Age Group And Bacterial Pneumonia 
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PRESENTING SYMPTOMS IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed, the most common presenting symptom was cough with 
expectoration, followed by hemoptysis, cough, dyspnea and fever in that order, 
with a P-value of 0.093 
CORRELATION BETWEEN SYMPTOMS AND TUBERCULOSIS 
DIAGNOSIS 
 
TB 
Total 
Chi Square 
Other 
Diagnosis Tuberculosis P-Value 
SYMPTOMS 
Cough 2 1 3 
  
0.093 
  
  
  
  
Cough With 
Expectoration 13 17 30 
Dyspnea 8 1 9 
Chest Pain 4 0 4 
Hemoptysis 3 3 6 
Fever 2 1 3 
Total 32 23 55 
     
Fig 30: Correlation Between Presenting Symptoms And  
Tuberculosis Diagnosis 
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PRESENTING SYMPTOMS IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed, the most common presenting symptom was chest pain, followed by 
hemoptysis, cough with expectoration and cough in that order, with a P-value 
of 0.000 which is statistically significant. 
CORRELATION BETWEEN SYMPTOMS AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma 
Total 
Chi 
Square 
Other 
diagnosis Carcinoma 
P-Value 
 
 
 
 
SYMPTOMS 
Cough 2 1 3 
  
  
0.000 
  
  
  
Cough With 
Expectoration 
29 1 30 
Dyspnea 9 0 9 
Chest Pain 0 4 4 
Hemoptysis 4 2 6 
Fever 3 0 3 
Total 47 8 55 
Fig 31: Correlation Between Presenting Symptoms And  
Carcinoma Diagnosis 
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PRESENTING SYMPTOMS IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed, the most common presenting symptom was cough with 
expectoration followed by fever in that order, with a P-value of 0.264 
CORRELATION BETWEEN SYMPTOMS AND BACTERIAL 
PNEUMONIA 
 
Bacterial pneumonia 
Total 
Chi Square 
Other 
diagnosis 
Bacterial 
pneumonia P-Value 
 
 
 
 
SYMPTOMS 
Cough 3 0 3 
  
 0.264 
 
  
  
  
Cough With 
Expectoration 
23 7 30 
Dyspnea 9 0 9 
Chest Pain 4 0 4 
Hemoptysis 6 0 6 
Fever 2 1 3 
Total 47 8 55 
 
 
Fig 32: Correlation Between Presenting Symptoms And Bacterial 
Pneumonia Diagnosis 
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SYMPTOM DURATION IN TUBERCULOSIS: 
Out of 55 patients in our study, in those patients where tuberculosis was 
diagnosed the symptom duration in a majority of patients was 4-6 weeks and  
6-8 weeks, followed by >8 weeks, with a P-value of 0.000 which is 
statistically significant. 
CORRELATION BETWEEN SYMPTOM DURATION AND 
TUBERCULOSIS DIAGNOSIS 
 
TB 
Total 
Chi Square 
Other 
Diagnosis Tuberculosis P-Value 
Symptom 
Duration 
4-6 Weeks 11 10 21 
0.000 
 
 
6-8 Weeks 2 10 12 
>8 Weeks 19 3 22 
Total 32 23 55 
      
 
Fig 33: Correlation Between Symptom Duration And Tuberculosis 
Diagnosis 
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SYMPTOM DURATION IN CARCINOMA: 
Out of 55 patients in our study, in those patients where carcinoma was 
diagnosed the symptom duration in a majority of patients was >8 weeks and  
4-6 weeks with a P-value of 0.270 
CORRELATION BETWEEN SYMPTOM DURATION AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma Tot
al 
Chi 
Square 
Other 
diagnosis Carcinoma 
P-Value 
Symptom 
Duration 
4-6 Weeks 17 4 21 
  
0.270 
  
6-8 Weeks 12 0 12 
>8 Weeks 18 4 22 
Total 47 8 55 
 
 
 
 
 
Fig 34: Correlation Between Symptom Duration And  
Carcinoma Diagnosis 
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SYMPTOM DURATION IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in those patients where bacterial 
pneumonia was diagnosed the symptom duration in a majority of patients was 
>8 weeks, and 4-6 weeks, with a P-value of 0.270 
CORRELATION BETWEEN SYMPTOM DURATION AND BACTERIAL 
PNEUMONIA 
 
Bacterial pneumonia Total 
Chi 
Square 
Other 
Diagnosis 
Bacterial 
pneumonia P-Value 
 
Symptom 
Duration 
4-6 Weeks 17 4 21 
0.270 
 
  
6-8 Weeks 12 0 12 
>8 Weeks 18 4 22 
Total 47 8 55 
 
 
Fig 35: Correlation Between Symptom Duration And Bacterial Pneumonia 
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CO MORBIDITIES  IN TUBERCULOSIS: 
Out of the 18 patients with DIABETES, 50% of them were diagnosed 
with TUBERCULOSIS with a P-value of 0.024 which is statistically 
significant. 
CORRELATION BETWEEN CO MORBIDITY AND TUBERCULOSIS DIAGNOSIS 
Co morbidity 
Tb 
Total 
Chi Square 
Other 
Diagnosis 
Tuberculosis 
Diagnosis P-Value 
Diabetes 
No 23 14 37 
0.024 
Yes 9 9 18 
COPD 
No 23 22 45 
0.391 
Yes 9 1 10 
Renal failure 
No 31 21 52 
0.370 
Yes 1 2 3 
Asthma 
No 30 23 53 
0.222 
Yes 2 0 2 
Anaemia 
No 31 21 52 
0.370 
Yes 1 2 3 
Others 
No 30 16 46 
0.017 
Yes 2 7 9 
Total 32 23 55  
Fig 36: correlation between co morbidities and tuberculosis diagnosis  
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CO MORBIDITIES  IN CARCINOMA: 
Out of the 10 patients with COPD, 50% of them were diagnosed with 
CARCINOMA with a P-value of 0.000 which is statistically significant. 
CORRELATION BETWEEN CO MORBIDITIES  AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma Total Chi Square Other diagnosis Carcinoma P-Value 
 
Diabetes 
No 30 7 37 0.187 
Yes 17 1 18 
 
COPD 
No 42 3 45 
0.000 Yes 5 5 10 
 
Renal failure 
No 44 8 52 
0.462 Yes 3 0 3 
 
Asthma 
No 45 8 53 
0.552 Yes 2 0 2 
 
Anaemia 
No 45 7 52 
0.342 Yes 2 1 3 
 
Others 
No 38 8 46 
0.176 Yes 9 0 9 
Total 47 8 55   
 
 
Fig 37: Correlation Between Co Morbidities  And Carcinoma Diagnosis 
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LOBES INVOLVED IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common lobe involved was left upper lobe followed by 
diffuse involvement, right upper lobe, right middle lobe and left lower lobe in 
that order, with a P-value of 0.037 which is statistically significant. 
CORRELATION BETWEEN LOBES INVOLVED AND TUBERCULOSIS 
DIAGNOSIS 
 
TB 
Total 
Chi Square 
Other 
Diagnosis Tuberculosis P-Value 
Lobes 
Involved 
Left lower lobe 5 2 7 
0.037 
 
 
 
 
 
Left upper lobe 4 10 14 
Right lower lobe 6 0 6 
Right middle lobe 1 3 4 
Right upper lobe 9 3 12 
Diffuse 
involvement 7 5 12 
Total 32 23 55 
     
 
Fig 38: Correlation Between Lobes Involved And Tuberculosis Diagnosis 
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LOBES INVOLVED IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common lobe involved was right upper lobe, followed by 
left upper lobe, right lower lobe and left lower lobe in that order, with a P-value 
of 0.462 
CORRELATION BETWEEN LOBES INVOLVED AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma 
Total 
Chi 
Square 
Other 
Diagnosis Carcinoma 
P-Value 
 
 
 
Lobes 
Involved 
Left lower lobe 6 1 7 
0.462 
 
 
 
 
 
Left upper lobe 12 2 14 
Right lower lobe 4 2 6 
Right middle lobe 4 0 4 
Right upper lobe 9 3 12 
Diffuse 
involvement 
12 0 12 
Total 47 8 55 
 
Fig 39: Correlation Between Lobes Involved And Carcinoma Diagnosis 
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LOBES INVOLVED IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common lobe involved was right upper lobe, followed 
by left lower lobe, right lower lobe and right middle lobe, in that order with a 
P-value of 0.157 
CORRELATION BETWEEN LOBES INVOLVED AND BACTERIAL 
PNEUMONIA DIAGNOSIS 
 
Bacterial pneumonia Total 
Chi 
Square 
Other 
Diagnosis 
Bacterial 
Pneumonia P-Value 
 
 
 
 
Lobes 
Involved 
Left Lower Lobe 5 2 7 
0.157 
  
  
  
  
  
Left Upper Lobe 14 0 14 
Right Lower Lobe 5 1 6 
Right Middle Lobe 3 1 4 
Right Upper Lobe 8 4 12 
Diffuse Involvement 12 0 12 
Total 47 8 55 
 
 
Fig 40: Correlation Between Lobes Involved And  
Bacterial Pneumonia Diagnosis 
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FOB FINDINGS IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common fob finding was purulent secretions, followed by 
mucosal inflammation, mucous plugging and blood stained secretions, with a 
P-value of 0.031 which is statistically significant. 
CORRELATION BETWEEN FOB FINDINGS AND TUBERCULOSIS 
DIAGNOSIS 
 
TB 
Total 
Chi Square 
Other 
Diagnosis Tuberculosis P-Value 
Fob 
Findings 
Blood Stained 
Secretions 2 1 3 
0.031 
  
  
  
  
Intraluminal 
Granulation 
Tissue/Mass 
5 0 5 
Mucosal 
Inflammation 15 6 21 
Mucous 
Plugging 0 2 2 
Purulent 
Secretions 10 14 24 
Total 32 23 55 
     
 
Fig 41: Correlation Between Fob Findings And Tuberculosis Diagnosis 
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FOB FINDINGS IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common fob finding was intraluminal mass followed by 
mucosal inflammation, with a P-value of 0.000 which is statistically 
significant. 
CORRELATION BETWEEN FOB FINDINGS AND CARCINOMA 
DIAGNOSIS 
 
Carcinoma 
Total 
Chi 
square 
Other 
Diagnosis Carcinoma 
P-value 
 
 
 
Fob 
Findings 
Blood stained 
secretions 3 0 3 
 0.000 
 
  
  
  
Intraluminal 
granulation 
tissue/mass 
0 5 5 
Mucosal 
inflammation 18 3 21 
Mucous plugging 2 0 2 
Purulent secretions 24 0 24 
TOTAL 47 8 55 
 
Fig 42: Correlation Between Fob Findings And Carcinoma Diagnosis 
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FOB FINDINGS IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common fob finding was purulent secretions, followed 
by mucosal inflammation, with a P-value of 0.114 
CORRELATION BETWEEN FOB FINDINGS AND BACTERIAL PNEUMONIA 
 
Bacterial pneumonia 
Total 
Chi Square 
Other diagnosis 
Bacterial 
pneumonia P-Value 
 
 
 
Fob 
Findings 
Blood Stained 
Secretions 
3 0 3 
0.114 
  
  
  
  
Intraluminal 
Granulation 
Tissue/Mass 
5 0 5 
Mucosal 
Inflammation 
20 1 21 
Mucous plugging 2 0 2 
Purulent 
secretions 
17 7 24 
Total 47 8 55 
 
 
Fig 43: Correlation Between Fob Findings And Bacterial Pneumonia 
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SMOKING INDEX AND CARCINOMA: 
Out of 55 patients, in 8 patients where carcinoma was diagnosed, 5 of 
them were heavy smokers, with a P-value of 0.097 
CORRELATION BETWEEN SMOKING INDEX AND CARCINOMA 
 
Carcinoma 
Total 
Chi Square 
Other  
diagnosis Carcinoma 
P-Value 
SMOKING 
INDEX 
MODERATE 
SMOKER (101 to 
300) 
8 0 8 
0.097 
  HEAVY 
SMOKER (>300) 
13 5 18 
Total 21 5 26 
 
 
Fig 44: Correlation Between Smoking Index And Carcinoma 
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CORRELATION BETWEEN BRONCHIAL WASH GENE XPERT 
AND BRONCHIAL WASH AFB SMEAR: 
In 23 patients where gene xpert was positive (MTB DETECTED), 
Bronchial wash AFB SMEAR was positive in 12 patients and there was no 
extra yield with Bronchial wash AFB SMEAR when Bronchial wash GENE 
XPERT is used, with a P-value of 0.000 which is statistically significant. 
CORRELATION BETWEEN BRONCHIAL WASH GENE XPERT AND 
AFB SMEAR 
 
 AFB smear Tota
l 
Chi 
Square 
Negative Positive P-Value 
Gene 
Xpert 
MTB not detected 32 0 32 
0.000 
  
MTB detected 11 12 23 
Total 43 12 55 
 
 
Fig 45: Correlation Between Bronchial Wash Gene Xpert And AFB Smear 
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CORRELATION BETWEEN BRONCHIAL WASH GENE XPERT AND 
POST FOB SPUTUM AFB SMEAR: 
In 23 patients where Bronchial wash gene xpert was positive (MTB 
DETECTED), POST FOB SPUTUM  AFB SMEAR was positive in 4 patients 
and there was no extra yield with POST FOB SPUTUM  AFB SMEAR when 
Bronchial wash GENE XPERT is used, with a P-value of 0.014 which is 
statistically significant. 
CORRELATION BETWEEN BRONCHIAL WASH GENE XPERT AND 
POST FOB SPUTUM  AFB SMEAR 
 
POST FOB SPUTUM 
AFB SMEAR Total 
Chi 
Square 
POSITIVE NEGATIVE P-Value 
GENE 
XPERT 
MTB NOT 
DETECTED 
0 32 32 
0.014 
  
MTB DETECTED 4 19 23 
Total 4 51 55 
      
Fig 46: Correlation Between Bronchial Wash Gene Xpert And Post Fob 
Sputum AFB Smear 
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CORRELATION BETWEEN BRONCHIAL WASH AFB SMEAR 
AND POST FOB SPUTUM AFB SMEAR: 
In 12 patients where Bronchial wash AFB SMEAR was positive, POST 
FOB SPUTUM AFB SMEAR was positive in 4 patients and there was no extra 
yield with POST FOB SPUTUM AFB SMEAR when Bronchial wash AFB 
SMEAR is used, with a P-value of 0.000 which is statistically significant. 
CORRELATION B/W BRONCHIAL WASH  AFB AND POST FOB 
SPUTUM AFB SMEAR 
 
Post fob Sputum AFB 
smear Total 
Chi 
Square 
Positive Negative P-Value 
Bronchial 
wash  AFB 
smear 
Negative 0 43 43 
0.000 
  
Positive 4 8 12 
Total 4 51 55 
 
Fig 47: Correlation Between Bronchial Wash AFB Smear And  
Post Fob Sputum AFB Smear 
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DISCUSSION 
AGE DISTRIBUTION: 
A total number of 55 patients who satisfied the inclusion and exclusion 
criteria were included in our study. The mean age of the total 55 patients was 
49.3 years with a standard deviation of 12.5. The age of the patients ranged 
from 20 years-69 years. The percentage of the patients belonging to the 5 age 
groups namely  <30 years, 31-40 years, 41-50 years, 51-60 years and  >60 
years were 10.9%,  10.9%,  23.6%,  38.2%  and  16.4% respectively.  
GENDER DISTRIBUTION: 
Out of the total 55 patients, 44 patients were males and 11 patients were 
females. Thus males accounted for 80% of our study population while females 
accounted for 20%.  
PATIENT’S EDUCATIONAL STATUS: 
In our study, out of 55 patients 49.1% were illiterate and 18.2% 
completed primary school, 10.9% completed middle school, 7.3% completed 
high school, 9.1% completed higher secondary school, 1.8% completed 
diploma and 3.6% completed post graduate degree diploma. 
GROSS TOTAL INCOME PER DAY: 
The gross total income of the family in our study was less than or equal 
to 250 Rupees in 28 patients, 251-500 Rupees in 18 patients and 501-1000 
Rupees in 9 patients.  
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PRESENTING SYMPTOMS: 
The presenting symptom of the patients in our study was cough with 
expectoration in 54.5% of patients, dyspnea in 16.4%, hemoptysis in 10.9%, 
chest pain in 7.3%, dry cough in 5.5% and fever in 5.5%. 
DURATION OF SYMPTOMS: 
The duration of symptoms in our study were divided into 3 groups 
namely 4-6 weeks, 6-8 weeks and >8 weeks. 22 of our patients had a symptom 
duration of >8 weeks, 21 patients had a symptom duration of 4-6 weeks and 12 
patients had a symptom duration of 6-8 weeks. Our study suggests that 
majority of the patients 22 in number, it took >8 weeks to label them as non-
resolving pneumonia and it took further time to diagnose the cause. Further if 
the patient was diagnosed to have tuberculosis he/she would have remained 
infectious throughout the whole period, and if malignancy is diagnosed the 
staging of the malignancy will go up from bad to worse during that period. 
PAST HISTORY OF RESPIRATORY ILLNESS: 
Among 55 patients in our study 65.5% patients had no prior respiratory 
illness and 34.5% had a past history of respiratory illness. 
SMOKING STATUS OF STUDY POPULATION 
Out of 55 patients in our study, 47.3% were smokers, 52.7% were non-
smokers. None of the female patients were smokers. Out of the smokers, 31% 
were moderate smokers, 69% were heavy smokers.  
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HISTORY OF ALCOHOL CONSUMPTION IN STUDY 
POPULATION: 
Out of 55 patients in our study, 54.5% patients had a history of chronic 
alcohol intake. 45.5% patients were non-alcoholics. None of the female 
patients in our study were alcoholics. 
CO MORBIDITIES : 
Out of the 55 patients in our study, 45 patients had a history of  
co morbid disease. 10 patients had no history of any co morbidities . Among 
the patients with co morbidities , diabetes was present in 40%, COPD in 
22.22%, renal failure in 6.67%, anaemia in 6.67%, bronchial asthma in 4.44% 
and other co morbidities  in 20%. 
AUSCULTATORY FINDING: 
Of the total 55 patients in our study, crackles was the most common 
auscultatory finding in 80%, wheeze in 14.5% and diminished breath sounds in 
5.5%. 
LOBES INVOLVED: 
In our study the lobes involved in the patients were assessed using a 
computed tomography chest. Left upper lobe was involved in 25.4%, right 
upper lobe in 21.8%, diffuse involvement again in 21.8%, left lower lobe in 
12.7% , right lower lobe in 10.9%, and right middle lobe in 7.3%.  
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BRONCHOSCOPY FINDINGS: 
Out of 55 patients in our study the most common bronchoscopic finding 
was purulent secretions in 43.6%, mucosal inflammation in 38.2%, 
intraluminal mass/granulation tissue in 9.1%, blood stained secretions in 5.5 
and mucous plugging in 3.6%. 
BRONCHIAL WASH GENE XPERT: 
Out of 55 patients, in our study Bronchial wash Gene Xpert had a result 
of MTB DETECTED in 41.8% and MTB NOT DETECTED in 58.2%. 
GENE XPERT RIFAMPICIN RESISTANCE: 
Out of 23 patients in whom MTB DETECTED all 23 patients had a 
result of RIFAMPICIN RESISTANCE-NOT DETECTED. 
BRONCHIAL WASH AFB SMEAR: 
Out of 55 patients in our study Bronchial wash AFB smear was positive 
in 21.8% and negative in 78.2%. 
BRONCHIAL WASH BACTERIAL CULTURE: 
Out of the total 55 patients in our study, Bronchial wash BACTERIAL 
CULTURE was contributory in arriving at a diagnosis in 14.5% of patients 
(n=8). The 8 Bronchial wash CULTURE SENSITIVITY results that are 
contributory to the diagnosis are ACINETOBACTER, E.COLI, KLEBSIELLA 
PNEUMONIAE, NOCARDIA SPECIES, PSEUDOMONAS AERUGINOSA, 
PROTEUS MIRABILIS, PROTEUS VULGARIS and ACTINOMYCETES. 
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BRONCHIAL WASH CYTOLOGY REPORTS: 
Out of the total 55 patients in our study a cytology report of acute 
inflammatory pathology was obtained in 54.5% of patients, chronic 
inflammatory pathology in 32.7% of patients and atypical cells seen(positive 
for malignancy) in 12.7% of patients. 
BRONCHIAL WASH FUNGAL SMEAR/CULTURE: 
Out of the 55 patients in our study none had a positive fungal 
smear/culture. 
ENDOBRONCHIAL BIOPSY: 
Out of the 55 patients in our study, endobronchial biopsy was done in 6 
patients and was contributory to the diagnosis in all 6 of them. 4 cases were 
diagnosed as carcinoma, 1 as carcinoid tumor and 1 as fungal pneumonia 
(mucormycosis). 
TRANSBRONCHIAL LUNG BIOPSY (TBLB): 
Out of the 55 patients in our study, TBLB was done in 3 patients and it 
was contributory to diagnosis in all 3 patients. 1 case was diagnosed as BOOP, 
1 as Chronic HSP (bird fanciers lung) and 1 actinomycetes pneumonia. 
CT-GUIDED BIOPSY: 
Out of the 55 patients in our study, CT-GUIDED BIOPSY was done in 
4 patients and it was contributory to diagnosis in all 4 patients. 3 cases were 
diagnosed as carcinoma and 1 as lipoid pneumonia. 
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POST FOB SPUTUM AFB SMEAR: 
Out of 55 patients in our study, POST FOB SPUTUM AFB SMEAR 
was done in all 55 patients and it was positive and contributory to the diagnosis 
in 4 patients. 
POST FOB SPUTUM CYTOLOGY: 
Out of the 55 patients in our study, POST FOB SPUTUM CYTOLOGY 
was done in all 55 patients and it was contributory in diagnosing the cause of 
NRP in 4 patients. 
ETIOLOGY DIAGNOSED: 
Out of the 55 patients in our study, etiology of NRP was diagnosed in 
92.7% (n=51) of patients and not diagnosed in 7.3% (n=4) of patients. 
TUBERCULOSIS (n=23), BACTERIAL PNEUMONIA (n=8), CARCINOMA 
INCLUDING ONE MALIGNANT CARCINOID TUMOR (n=8), ALLERGIC 
BRONCHOPULMONARY ASPERGILLOSIS (n=2), CHRONIC 
HYPERSENSITIVITY PNEUMONITIS (n=2), SILICOSIS (n=3), SLE 
PNEUMONITIS (n=1), BRONCHIOLITIS OBLITERANS ORGANISING 
PNEUMONIA(BOOP) (n=1), FUNGAL PNEUMONIA (MUCOR) (n=1) , 
DAH WITH PULMONARY RENAL SYNDROME (n=1), LIPOID 
PNEUMONIA (n=1) and UNDIAGNOSED (n=4). 
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AGE DISTRIBUTION IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common age group affected  was 50-60 years, followed by 
41-50 years, >60 years, <30 years and 31-40 years in that order, with a P-value 
of 0.504 
AGE DISTRIBUTION IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common age group affected  was 51-60 years, followed by 
>60 years, 41-50 years and <30 years in that order with a P-value of 0.680 
AGE DISTRIBUTION IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common age group affected  was 41-50 years, 
followed by >60 years, 51-60 years and 31-40 years in that order with a P-
value of 0.211 
PRESENTING SYMPTOMS IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed, the most common presenting symptom was cough with 
expectoration, followed by hemoptysis, cough, dyspnea and fever in that order, 
with a P-value of 0.09 
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PRESENTING SYMPTOMS IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed, the most common presenting symptom was chest pain, followed by 
hemoptysis, cough with expectoration and cough in that order, with a P-value 
of 0.000 which is statistically significant. 
PRESENTING SYMPTOMS IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed, the most common presenting symptom was cough with 
expectoration followed by fever in that order, with a P-value of 0.264 
SYMPTOM DURATION IN TUBERCULOSIS: 
Out of 55 patients in our study, in those patients where tuberculosis was 
diagnosed the symptom duration in a majority of patients was 4-6 weeks and  
6-8 weeks, followed by >8 weeks, with a P-value of 0.000 which is 
statistically significant. 
SYMPTOM DURATION IN CARCINOMA: 
Out of 55 patients in our study, in those patients where carcinoma was 
diagnosed the symptom duration in a majority of patients was >8 weeks and  
4-6 weeks with a P-value of 0.270 
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SYMPTOM DURATION IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in those patients where bacterial 
pneumonia was diagnosed the symptom duration in a majority of patients was 
>8 weeks, and 4-6 weeks, with a P-value of 0.270 
DIABETES AND TUBERCULOSIS: 
Out of the 18 patients with DIABETES, 50% of them were diagnosed with 
TUBERCULOSIS with a P-value of 0.024 which is statistically significant. 
COPD AND CARCINOMA: 
Out of the 10 patients with COPD, 50%(n=5) of them were diagnosed with 
CARCINOMA with a P-value of 0.000 which is statistically significant. 
LOBES INVOLVED IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common lobe involved was left upper lobe followed by 
diffuse involvement, right upper lobe, right middle lobe and left lower lobe in 
that order, with a P-value of 0.037 which is statistically significant. 
LOBES INVOLVED IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common lobe involved was right upper lobe, followed by 
left upper lobe, right lower lobe and left lower lobe in that order, with a P-value 
of 0.462 
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LOBES INVOLVED IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common lobe involved was right upper lobe, followed 
by left lower lobe, right lower lobe and right middle lobe, in that order with a 
P-value of 0.157 
FOB FINDINGS IN TUBERCULOSIS: 
Out of 55 patients in our study, in patients where tuberculosis was 
diagnosed the most common fob finding was purulent secretions, followed by 
mucosal inflammation, mucous plugging and blood stained secretions, with a 
P-value of 0.031 which is statistically significant. 
FOB FINDINGS IN CARCINOMA: 
Out of 55 patients in our study, in patients where carcinoma was 
diagnosed the most common fob finding was intraluminal mass followed by 
mucosal inflammation, with a P-value of 0.000 which is statistically 
significant. 
FOB FINDINGS IN BACTERIAL PNEUMONIA: 
Out of 55 patients in our study, in patients where bacterial pneumonia 
was diagnosed the most common fob finding was purulent secretions, followed 
by mucosal inflammation, with a P-value of 0.114 
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SMOKING AND CARCINOMA: 
Out of 55 patients, in 8 patients where carcinoma was diagnosed, 5 of 
them were heavy smokers, with a P-value of 0.097 
BRONCHIAL WASH GENE XPERT Vs BRONCHIAL  
WASH AFB SMEAR: 
In 23 patients where Bronchial wash gene xpert was positive (MTB 
DETECTED), Bronchial wash AFB SMEAR was positive in 12 patients and 
there was no extra yield with Bronchial wash AFB SMEAR when Bronchial 
wash GENE XPERT is used, with a P-value of 0.000 which is statistically 
significant. 
BRONCHIAL WASH GENE XPERT Vs POST FOB  
SPUTUM AFB SMEAR: 
In 23 patients where Bronchial wash gene xpert was positive (MTB 
DETECTED), POST FOB SPUTUM AFB SMEAR was positive in 4 patients 
and there was no extra yield with POST FOB SPUTUM AFB SMEAR when 
Bronchial wash GENE XPERT is used, with a P-value of 0.014 which is 
statistically significant. 
BRONCHIAL WASH AFB SMEAR Vs POST FOB  
SPUTUM AFB SMEAR: 
In 12 patients where Bronchial wash AFB SMEAR was positive, POST 
FOB SPUTUM AFB SMEAR was positive in 4 patients and there was no extra 
yield with POST FOB SPUTUM AFB SMEAR when Bronchial wash AFB 
SMEAR is used, with a P-value of 0.000 which is statistically significant. 
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CONCLUSION 
1. Non-resolving pneumonia was observed to be more common in 
patients >40 years of age which constitutes around 80% of study 
population. 
2. In our study it was observed that Non-resolving pneumonia was 
more common in males compared to females with the ratio of 4:1. 
3. Majority of the patients in our study were from low income group 
and illiterates. 
4. The most common presenting symptom was persistent cough with 
expectoration. 
5. Chest pain followed by hemoptysis were the presenting symptoms 
when cause for non-resolving pneumonia was diagnosed as 
malignancy. 
6. Almost all of the patients in our study had a symptom duration of at 
least 4 weeks which implies health seeking behaviour of patients is 
not satisfactory (or) these patients were referred late to our 
institution. Hence, patients should be referred early to tertiary care 
units for evaluation, once non-resolving pneumonia is suspected. 
7. Smoking and alcoholism was found to be associated with non-
resolving pneumonia in 47% patients and 55% patients 
respectively. 
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8. Non resolving pneumonia was found to be associated with  
co morbidities in around 80% of our study population. Diabetes 
mellitus (40%) and COPD (22%) were the most common  
co morbidities.  
9. Non resolving pneumonia in diabetic patients is more likely to be 
tuberculosis with 50% of diabetics in our study were diagnosed with 
tuberculosis. 
10. Non resolving pneumonia in COPD patients, is an ominous sign, 
more chances of it being diagnosed as malignancy. 
11. Bronchoscopy was found to be a safe and useful procedure in non-
resolving pneumonia patients and no serious complications were 
encountered. The diagnostic yield of bronchoscopy in our study was 
71%. 
12. Tuberculosis was the most common cause for non-resolving 
pneumonia in around 42% of patients. Bacterial pneumonia (15%) 
and malignancy (15%) were the next two causes. 
13. Bronchial wash Gene Xpert, as a single investigation has a 
diagnostic yield of around 42% in non-resolving pneumonia.  
14. Bronchial wash Gene Xpert has an additional yield of 48% in 
diagnosing tuberculosis against Bronchial wash AFB smear.  
15. Bronchial wash Gene Xpert has an additional yield of 83% in 
diagnosing tuberculosis against Post Bronchoscopy sputum AFB 
smear. 
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16. Our study suggests that Bronchial wash Gene Xpert can be included 
in the non-resolving pneumonia investigation panel, because it has a 
good diagnostic yield and provides an early diagnosis of tuberculosis 
before the patient becomes bronchial wash AFB or sputum AFB 
smear positive. 
17. Early bronchoscopy (after 2 weeks of antibiotics), is needed in non-
resolving pneumonia for early diagnosis of tuberculosis.
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ABBREVIATIONS 
COPD – Chronic Obstructive Pulmonary Disease 
MTB – Mycobacterium tuberculosis 
HIV – Human Immunodeficiency Virus 
FOB – Fiber optic bronchoscopy 
HAP – Hospital Acquired Pneumonia 
VAP – Ventilator Associated Pneumonia 
CB NAAT – Cartridge Based Nucleic Acid Amplification Test 
HSP – Hyper Sensitivity Pneumonitis 
SLE pneumonitis – Systemic Lupus Erythematosus pneumonitis 
ABPA – Allergic Broncho Pulmonary Aspergillosis 
BOOP – Bronchiolitis Obliterans Organising Pneumonia 
DAH – Diffuse Alveolar Haemorrhage 
AFB – Acid Fast Bacilli 
PCP – Pneumocystis Carinii Pneumonia 
CAD – Coronary Artery Disease 
NTM – Non Tuberculous Mycobacteria 
AIDS – Acquired Immune Deficiency Syndrome 
MRSA – Methcillin Resistant Staphylococcus Aureus 
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PATIENT INFORMATION SHEET 
 
TITLE OF THE STUDY: “To study the socio-demographic, microbio-
pathological, clinico-radiological profile and etiology of patients with non-resolving 
pneumonia in a tertiary care hospital” 
 
We are conducting a study on among patients admitted in Rajiv Gandhi 
Government General Hospital, Chennai. 
  
The purpose of this study is to   analyze the socio-demographic, microbio-
pathological and clinico-radiological profile and etiology of patients with non-
resolving pneumonia in a tertiary care hospital. 
 
We are  selecting cases  based on diagnosis of non-resolving pneumonia as per 
the definition and the selected patients will undergo basic blood investigations, CT 
chest(if needed),fiber-optic bronchoscopy and CT guided biopsy(if necessary)to 
arrive at a diagnosis and subsequently treat the patient. 
 
 The  privacy  of  the  patients  in  the  research  will  be  maintained   
throughout   the study. In the event of any publication or presentation resulting from 
the research, no personally identifiable information will be shared. 
  
 Taking part in this study is voluntary.  You  are  free  to  decide  whether  to  
participate in this  study  or  to  withdraw  at  any  time;  your  decision  will  not  
result  in any  loss of  benefits to which  you  are  otherwise  entitled.  
 
 The  results  of  the  special  study  may  be  intimated  to  you  at  the  end  of 
the study period  or during   the study if  anything  is found  abnormal  which  may  
aid  in  the  management  or treatment. 
 
 
 
Signature of Investigator    Signature of Participant 
 
Date : 
 
 
  
 
PATIENT CONSENT FORM 
 
Study Detail : “To study the socio-demographic, 
microbio-pathological, clinico-radiological 
profile and etiology of  patients with non-
resolving pneumonia in a tertiary care 
hospital ” 
Study Centre : Rajiv Gandhi Government General 
Hospital, Chennai. 
Patient’s 
Name 
:  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (√) these boxes 
a) I confirm that I have understood the purpose of procedure for the 
above study. I have the opportunity to ask question and all my 
questions and doubts have been answered to my complete 
satisfaction.  
b) I understand that my participation in the study is voluntary and 
that I am free to withdraw at any time without giving reason, 
without my legal rights being affected.  
c) I understand that sponsor of the clinical study, others working on 
the sponsor’s behalf, the ethical committee and the regulatory 
authorities will not need my permission to look at my health 
records, both in respect of current study and any further research 
that may be conducted in relation to it, even if I withdraw from the 
study I agree to this access. However, I understand that my 
identity will not be revealed in any information released to third 
parties or published, unless as required under the law. I agree not 
to restrict the use of any data or results that arise from this study.  
d) I agree to take part in the above study and to comply with the 
instructions given during the study and faithfully cooperate with 
the study team and to immediately inform the study staff if I suffer 
from any deterioration in my health or well-being or any 
unexpected or unusual symptoms.  
e) I hereby consent to participate in this study.  
f) I hereby give permission to undergo detailed clinical examination, 
Radiographs, blood investigations and surgical procedure as 
required.  
Signature of Investigator    Signature of Participant 
Date &time :      Name and address 
Place  : 
  
 
 
 
 
 
  
 
 
 
  
  
 
EVALUATION FORM 
Name: 
 
Age: 
 
Sex: 
 
ID/IP number: 
 
Ward: 
 
Socio-demographic history: 
 
Presenting complaints: 
 
History of presenting illness: 
 
Past history: 
 
Treatment history: 
 
Personal history: 
 
Occupational history: 
 
General examination: 
 
Systemic examination: 
 
Blood investigations: 
 
Chest skiagram: 
 
CT-CHEST: 
 
Sputum investigations: 
 
Bronchoscopy findings and investigation results: 
 
Trans bronchial/CT guided biopsy reports: 
 
Final diagnosis: 
  
 
 
ID NAME AGE GENDER 
EDUCATION 
OF HEAD OF  
FAMILY 
OCCUPATION 
OF HEAD OF 
FAMILY 
GROSS TOTAL 
INCOME PER DAY 
PRESENTING 
COMPLAINTS 
DURATION 
IN WEEKS 
1 SANTHAIYAH 55 M UNEDUCATED COOLIE 450 
COUGH WITH 
EXPECTORATION 5 
2 GANESAN 63 M HIGH SCHOOL COOK 650 
COUGH WITH 
EXPECTORATION 10 
3 CHINNAPAIYAN 65 M UNEDUCATED COOLIE 300 CHEST PAIN 10 
4 GAJENDRAN 50 M 
PRIMARY 
SCHOOL COOLIE 350 
COUGH WITH 
EXPECTORATION 7 
5 AROKIYA SAMY 63 M UNEDUCATED COOLIE 400 HEMOPTYSIS 5 
6 MOHANAPRIYA 27 F 
PRIMARY 
SCHOOL CLERICAL 750 
COUGH WITH 
EXPECTORATION 7 
7 PANKAJAVALLI 59 F 
PRIMARY 
SCHOOL COOLIE 400 
COUGH WITH 
EXPECTORATION 7 
8 CENSAPPAN 67 M UNEDUCATED FARMER 250 CHEST PAIN 10 
9 SURESHKUMAR 36 M SECONDARY SCHOOL SKILLED WORK 700 
COUGH WITH 
EXPECTORATION 5 
10 MADHAIYAN 69 M UNEDUCATED FARMER 200 
COUGH WITH 
EXPECTORATION 5 
11 GOPAL 46 M UNEDUCATED COOLIE 300 
COUGH WITH 
EXPECTORATION 7 
12 ELUMALAI 25 M 
POST HIGH SCHOOL 
DIPLOMA CLERICAL 700 
COUGH WITH 
EXPECTORATION 5 
13 ABDUL AZIZ 57 M HIGH SCHOOL SEMI PROFESSION 800 
COUGH WITH 
EXPECTORATION 5 
14 KANAGA 45 F UNEDUCATED FARMER 250 DYSPNEA 10 
15 GOPINATHAN 22 M HIGHER SECONDARY SHOP OWNER 800 FEVER 7 
16 RAVI 52 M MIDDLE SCHOOL FARMER 300 CHEST PAIN 10 
17 NEELAGANDAN 53 M HIGHER SECONDARY CLERICAL 850 
COUGH WITH 
EXPECTORATION 5 
18 EMMAROSE 62 M MIDDLE SCHOOL FARMER 250 
COUGH WITH 
EXPECTORATION 5 
19 RAJENDRAN 42 M HIGHER SECONDARY FARMER 300 
COUGH WITH 
EXPECTORATION 7 
20 DHANAPAL 63 M UNEDUCATED FARMER 250 
COUGH WITH 
EXPECTORATION 10 
21 SIVAKUMAR 35 M 
POSTGRADUATE 
DIPLOMA OFFICE JOB 1000 HEMOPTYSIS 5 
22 DHANAM 48 F UNEDUCATED FARMER 300 
COUGH WITH 
EXPECTORATION 5 
23 GANESAN 60 M UNEDUCATED COOLIE 250 DYSPNEA 10 
24 RENUGA 50 F 
PRIMARY 
SCHOOL FARMER 200 COUGH  10 
25 RAGAIAH 50 M UNEDUCATED COOLIE 200 
COUGH 
WITHEXPECTORATION 10 
26 SRINIVASAN 63 M UNEDUCATED FARMER 150 
COUGH WITH 
EXPECTORATION 7 
27 KALIYAPERUMAL 55 M 
PRIMARY 
SCHOOL COOLIE 200 FEVER 5 
28 RAVICHANDRAN 53 M UNEDUCATED COOLIE 300 
COUGH WITH 
EXPECTORATION 7 
29 ARAVINDASAMY 20 M HIGH SCHOOL FARMER 150 
COUGH WITH 
EXPECTORATION 10 
30 PERUMAL 63 M UNEDUCATED COOLIE 200 DYSPNEA 10 
 
  
 
 
ID NAME 
PREVIOUS 
H/O 
RESP 
ILLNESS SMOKER 
SMOKING 
INDEX ALCOHOLISM CO MORBIDITIES 
CO MORBIDITY 
PRESENT CLINICAL FINDING 
1 SANTHAIYAH NO YES 500 YES YES RENAL FAILURE CRACKLES 
2 GANESAN YES YES 375 YES YES DIABETES CRACKLES 
3 CHINNAPAIYAN NO YES 420 YES YES COPD 
DIMINISHED 
BREATH SOUND 
4 GAJENDRAN YES YES 300 YES NO   CRACKLES 
5 AROKIYA SAMY YES YES 204 YES YES COPD CRACKLES 
6 MOHANAPRIYA NO NO   NO NO NO CRACKLES 
7 PANKAJAVALLI NO NO   NO YES DIABETES CRACKLES 
8 CENSAPPAN NO NO   NO YES ANAEMIA 
DIMINISHED 
BREATH SOUND 
9 SURESHKUMAR NO YES 240 YES YES 
HYPERTENSION 
DIABETES CRACKLES 
10 MADHAIYAN YES YES 400 NO YES DIABETES CRACKLES 
11 GOPAL YES YES 260 NO NO NO CRACKLES 
12 ELUMALAI NO NO   NO NO NO CRACKLES 
13 ABDUL AZIZ YES NO   YES YES DIABETES CRACKLES 
14 KANAGA NO NO   NO YES ANAEMIA CRACKLES 
15 GOPINATHAN NO NO   NO NO NO CRACKLES 
16 RAVI NO YES 400 YES YES DIABETES CRACKLES 
17 NEELAGANDAN NO YES 330 YES YES DIABETES CRACKLES 
18 EMMAROSE YES YES 420 YES YES 
GASTRIC 
ADENOCARCINOMA CRACKLES 
19 RAJENDRAN NO YES 220 YES YES DIABETES CRACKLES 
20 DHANAPAL NO NO   YES YES DIABETES CRACKLES 
21 SIVAKUMAR NO NO   NO NO NO CRACKLES 
22 DHANAM YES NO   NO YES DIABETES CRACKLES 
23 GANESAN NO YES 350 YES NO NO WHEEZE 
24 RENUGA NO NO   NO YES 
IDIOPATHIC 
THROMBOCYTOPENIA CRACKLES 
25 RAGAIAH NO YES 300 YES YES COPD CRACKLES 
26 SRINIVASAN NO NO   NO YES 
TONSILLAR 
CARCINOMA CRACKLES 
27 KALIYAPERUMAL NO YES 320 YES YES DIABETES CRACKLES 
28 RAVICHANDRAN YES YES 300 YES YES 
ILD 
DIABETES CRACKLES 
29 ARAVINDASAMY NO NO   NO NO NO CRACKLES 
30 PERUMAL YES YES 350 NO YES COPD WHEEZE 
 
  
 
 
ID NAME 
RADIOLOGICAL 
INVOLVEMENT FOB FINDINGS BAL GENE XPERT 
IF 
DETECTED 
GENE XPERT  
RIFAMPICIN 
SENSITIVITY BAL AFB BAL C/S BAL C/S IF YES 
1 SANTHAIYAH 
RIGHT UPPER 
LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
2 GANESAN 
RIGHT UPPER 
LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE CONTRIBUT ORY 
PROTEUS 
MIRABILIS 
ESBL 
3 CHINNAPAIYAN LEFT UPPER LOBE MUCOSAL INFLAMMATION 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
4 GAJENDRAN 
DIFFUSE 
INVOLVEMENT MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
5 AROKIYA SAMY 
RIGHT MIDDLE 
LOBE 
BLOOD STAINED 
SECRETIONS MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
6 MOHANAPRIYA LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
7 PANKAJAVALLI LINGULA PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
8 CENSAPPAN 
RIGHT LOWER 
LOBE INTRALUMINAL MASS 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
9 SURESHKUMAR LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
10 MADHAIYAN LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
11 GOPAL 
RIGHT MIDDLE 
LOBE MUCOUS PLUGGING MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
12 ELUMALAI LEFT UPPER LOBE MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
13 ABDUL AZIZ LEFT UPPER LOBE MUCOUS PLUGGING MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
14 KANAGA 
RIGHT UPPER 
LOBE MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
15 GOPINATHAN 
DIFFUSE 
INVOLVEMENT MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
16 RAVI LEFT UPPER LOBE MUCOSAL INFLAMMATION 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
17 NEELAGANDAN 
DIFFUSE 
INVOLVEMENT PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
18 EMMAROSE LEFT UPPER LOBE MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
19 RAJENDRAN LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
20 DHANAPAL LEFT LOWER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE CONTRIBUTORY NOCARDIA 
21 SIVAKUMAR 
DIFFUSE 
INVOLVEMENT 
BLOOD STAINED 
SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
22 DHANAM 
RIGHT LOWER 
LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE CONTRIBUTORY PSEUDOMONAS 
23 GANESAN 
DIFFUSE 
INVOLVEMENT MUCOSAL INFLAMMATION 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
24 RENUGA LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
25 RAGAIAH 
RIGHT UPPER 
LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE CONTRIBUTORY 
PROTEUSVULGA
RIS 
26 SRINIVASAN 
DIFFUSE 
INVOLVEMENT MUCOSAL INFLAMMATION MTB DETECTED SENSITIVE NEGATIVE 
NOT  
CONTRIBUTORY   
27 
KALIYAPERUMA
L LEFT LOWER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   NEGATIVE CONTRIBUTORY E.COLI 
28 RAVICHANDRAN 
DIFFUSE 
INVOLVEMENT PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTORY   
29 ARAVINDASAMY RIGHT LUNG INTRALUMINAL MASS 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
30 PERUMAL 
DIFFUSE 
INVOLVEMENT MUCOSAL INFLAMMATION 
MTB NOT 
DETECTED   NEGATIVE 
NOT  
CONTRIBUTORY   
  
 
ID NAME BAL CYTOLOGY 
BAL FUNGAL 
SMEAR 
BAL CELL 
COUNT 
ENDOBRONCHIA
L  
BIOPSY 
DONE OR NOT 
ENDOBRONCHIA
L 
BIOPSY 
CONTRIBUTORY 
OR NOT 
TBLB 
DONE 
OR 
NOT 
IF DONE 
TBLB 
CONTIRIBUTOR
Y  
OR NOT 
1 SANTHAIYAH 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
2 GANESAN 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
3 
CHINNAPAIYA
N 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
4 GAJENDRAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
5 
AROKIYA 
SAMY 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
6 
MOHANAPRIY
A 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
7 
PANKAJAVAL
LI 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
8 CENSAPPAN 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC DONE CONTRIBUTORY 
NOT 
DONE   
9 
SURESHKUMA
R 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
10 MADHAIYAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
11 GOPAL 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
12 ELUMALAI 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
13 ABDUL AZIZ 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
14 KANAGA 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
15 GOPINATHAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
16 RAVI 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
17 
NEELAGANDA
N 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
18 EMMAROSE 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
19 RAJENDRAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
20 DHANAPAL 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY EOSINOPHILIC NOT DONE   
NOT 
DONE   
21 SIVAKUMAR 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY 
MACROPHAGES(HE
MOSIDERIN  
LADEN) NOT DONE   
NOT 
DONE   
22 DHANAM 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
23 GANESAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY 
MACROPHAGE(PIG
MENT LADEN) NOT DONE   
NOT 
DONE   
24 RENUGA 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
25 RAGAIAH 
CHRONIC 
INFLAMMATORYPATHOL
OGY NOT CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
26 SRINIVASAN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
27 
KALIYAPERU
MAL 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
28 
RAVICHANDR
AN 
ACUTE INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
29 
ARAVINDASA
MY 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC DONE CONTRIBUTORY 
NOT 
DONE   
30 PERUMAL 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY 
MACROPHAGE(PIG
MENT LADEN) NOT DONE   
NOT 
DONE   
 
 
  
 
ID NAME 
TTNA 
DONE 
OR 
NOT 
IF DONE 
TTNA 
CONTRIBUTORY 
OR NOT 
CT 
GUIDED 
BIOPSY 
DONE OR 
NOT 
CT GUIDED 
BIOPSY 
CONTRIBUT
ORY OR 
NOT 
POST FOB 
AFB 
POST FOB 
CYTOLOGY 
ETIOLOGY  
DIAGNOSE
D OR NOT DIAGNOSIS 
1 SANTHAIYAH 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
2 GANESAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
BACTERIAL  
PNEUMONIA(PROTEUS) 
3 
CHINNAPAIYA
N DONE CONTRIBUTORY 
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
CONTRIBUTOR
Y YES 
SQUAMOUS CELL CARCINOMA 
(POORLY 
DIFFERENTIATED) 
4 GAJENDRAN 
NOT 
DONE   
NOT 
DONE   
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
5 
AROKIYA 
SAMY 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
6 MOHANAPRIYA 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
7 
PANKAJAVALL
I 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
8 CENSAPPAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
CONTRIBUTOR
Y YES 
SQUAMOUS CELL CARCINOMA 
(INFILTRATING) 
9 
SURESHKUMA
R 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
10 MADHAIYAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
11 GOPAL 
NOT 
DONE   
NOT 
DONE   
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
12 ELUMALAI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
13 ABDUL AZIZ 
NOT 
DONE   
NOT 
DONE   
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
14 KANAGA 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
15 GOPINATHAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
16 RAVI 
NOT 
DONE   DONE 
CONTRIBUT
ORY 
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES SARCOMATOID CARCINOMA 
17 NEELAGANDAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
18 EMMAROSE 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
19 RAJENDRAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
20 DHANAPAL 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
BACTERIAL 
PNEUMONIA(NOCARDIA) 
21 SIVAKUMAR 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
DAH WITH 
PULMONARY RENAL SYNDROME 
22 DHANAM 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
BACTERIAL  
PNEUMONIA(PSEUDOMONAS) 
23 GANESAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES SILICOSIS 
24 RENUGA 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
25 RAGAIAH 
NOT 
DONE   
NOT 
DONE   
NOT 
CONTRIBUTOR
Y 
NOT 
CONTRIBUTOR
Y YES 
BACTERIAL PNEUMONIA(PROTEUS 
VULGARIS) 
26 SRINIVASAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
27 
KALIYAPERUM
AL 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
BACTERIAL  
PNEUMONIA(E.COLI) 
28 
RAVICHANDRA
N 
NOT 
DONE   
NOT 
DONE   
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES TUBERCULOSIS 
29 
ARAVINDASAM
Y 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES 
CARCINOID 
TUMOR 
30 PERUMAL 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTOR
Y 
NOT  
CONTRIBUTOR
Y YES SILICOSIS 
 
 
  
 
ID NAME AGE GENDER 
EDUCATION 
OF HEAD OF  
FAMILY 
OCCUPATION 
OF HEAD OF 
FAMILY 
GROSS TOTAL 
INCOME PER DAY 
PRESENTING 
COMPLAINTS 
DURATION 
IN WEEKS 
31 KALIYARAJ 47 M 
PRIMARY 
SCHOOL FARMER 275 
COUGH WITH 
EXPECTORATION 10 
32 DURAISAMY 54 M UNEDUCATED FARMER 200 CHEST PAIN 5 
33 PITCHAIKANNU 49 M UNEDUCATED COOLIE 150 
COUGH WITH 
EXPECTORATION 5 
34 MOORTHY 31 M 
POSTGRADUATE 
DIPLOMA SEMI PROFESSION 1000 COUGH 5 
35 POOTHATHAN 60 M UNEDUCATED FARMER 200 
COUGH WITH 
EXPECTORATION 7 
36 SANTHAIYAH 55 M UNEDUCATED COOLIE 250 HEMOPTYSIS 10 
37 SAIDA BANU 22 F HIGHER SECONDARY FARMER 350 DYSPNEA 10 
38 PONNUSAMY 60 M UNEDUCATED COOLIE 175 DYSPNEA 7 
39 RANJITH PASWAN 40 M MIDDLE SCHOOL COOLIE 450 
COUGH WITH 
EXPECTORATION 5 
40 ANJALAI 24 F 
PRIMARY 
SCHOOL COOLIE 150 HEMOPTYSIS 5 
41 PERUMAL 55 M UNEDUCATED FARMER 200 
COUGH WITH 
EXPECTORATION 10 
42 BALAKRISHNAN 53 M MIDDLE SCHOOL FARMER 250 DYSPNEA 10 
43 SEMBIAN 60 M UNEDUCATED COOLIE 200 COUGH 5 
44 ZAIMUNISHA 45 F HIGH SCHOOL CLERICAL 350 
COUGH WITH 
EXPECTORATION 5 
45 JAYAKUMAR 47 M MIDDLE SCHOOL CLERICAL 500 HEMOPTYSIS 5 
46 RAJESWARI 57 F 
PRIMARY 
SCHOOL COOLIE 200 
COUGH WITH 
EXPECTORATION 7 
47 RANGAN 53 M UNEDUCATED FARMER 150 
COUGH WITH 
EXPECTORATION 10 
48 SRINIVASAN 51 M 
PRIMARY 
SCHOOL FARMER 200 DYSPNEA 10 
49 SHANKAR 41 M UNEDUCATED  COOLIE 250 DYSPNEA 10 
50 TAMILARASI 40 F MIDDLE SCHOOL COOLIE 275 DYSPNEA 10 
51 GOVINASAMY 53 M UNEDUCATED FARMER 450 HEMOPTYSIS 5 
52 NALLI 60 M UNEDUCATED FARMER 150 
COUGH WITH 
EXPECTORATION 10 
53 RAVI 55 M UNEDUCATED COOLIE 200 FEVER 5 
54 RAAKAIAH 40 M UNEDUCATED FARMER 250 
COUGH WITH 
EXPECTORATION 10 
55 MALA 43 F 
PRIMARY 
SCHOOL CLERICAL 500 
COUGH WITH 
EXPECTORATION 7 
                  
 
 
 
  
 
 
ID NAME 
PREVIOUS 
H/O 
RESP 
ILLNESS SMOKER 
SMOKING 
INDEX ALCOHOLISM CO MORBIDITIES 
CO MORBIDITY 
PRESENT CLINICAL FINDING 
31 KALIYARAJ YES YES 300 YES YES DIABETES CRACKLES 
32 DURAISAMY NO YES 600 YES YES COPD CRACKLES 
33 PITCHAIKANNU NO NO   YES NO NO CRACKLES 
34 MOORTHY NO NO   NO YES SLE CRACKLES 
35 POOTHATHAN NO NO   YES YES DIABETES CRACKLES 
36 SANTHAIYAH NO YES 350 NO YES RENAL FAILURE CRACKLES 
37 SAIDA BANU NO NO   NO NO NO WHEEZE 
38 PONNUSAMY NO NO   YES YES RENAL FAILURE WHEEZE 
39 RANJITH PASWAN NO NO   YES NO NO CRACKLES 
40 ANJALAI NO NO   NO YES ANAEMIA CRACKLES 
41 PERUMAL YES YES 450 YES YES DIABETES CRACKLES 
42 BALAKRISHNAN YES NO   NO YES ASTHMA WHEEZE 
43 SEMBIAN NO NO   YES NO NO 
DIMINISHED BREATH 
SOUND 
44 ZAIMUNISHA YES NO   NO YES 
RHEUMATOID 
ARTHRITIS CRACKLES 
45 JAYAKUMAR NO YES 600 YES YES COPD CRACKLES 
46 RAJESWARI NO NO   NO YES 
DIABETES 
HYPERTENSION CRACKLES 
47 RANGAN YES YES 550 YES YES COPD CRACKLES 
48 SRINIVASAN YES NO   YES YES HYPERTENSION CRACKLES 
49 SHANKAR YES NO   NO YES ASTHMA WHEEZE 
50 TAMILARASI YES NO   NO NO NO WHEEZE 
51 GOVINASAMY NO YES 450 YES YES COPD CRACKLES 
52 NALLI YES YES 450 YES YES DIABETES CRACKLES 
53 RAVI NO YES 350 YES YES COPD CRACKLES 
54 RAAKAIAH NO NO   NO NO NO WHEEZE 
55 MALA NO NO   NO YES DIABETES CRACKLES 
                  
 
 
  
 
 
 
ID NAME 
RADIOLOGICAL 
INVOLVEMENT FOB FINDINGS BAL GENE XPERT 
IF DETECTED 
GENE XPERT  
RIFAMPICIN 
SENSITIVITY BAL AFB BAL C/S BAL C/S IF YES 
31 KALIYARAJ RIGHT UPPER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
32 DURAISAMY RIGHT UPPER LOBE INTRALUMINAL MASS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
33 PITCHAIKANNU RIGHT UPPER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   
NEGATIV
E 
CONTRIBUTOR
Y KLEBSIELLA 
34 MOORTHY LEFT LOWER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
35 POOTHATHAN LEFT LOWER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTOR
Y   
36 SANTHAIYAH RIGHT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE 
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
37 SAIDA BANU 
DIFFUSE 
INVOLVEMENT 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
38 PONNUSAMY 
DIFFUSE 
INVOLVEMENT 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
39 
RANJITH 
PASWAN RIGHT MIDDLE LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
CONTRIBUTOR
Y 
ACINETOBACTE
R 
40 ANJALAI LEFT UPPER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTOR
Y   
41 PERUMAL LEFT LOWER LOBE 
INTRALUMINAL 
GRANULATION 
TISSUE 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
42 
BALAKRISHNA
N RIGHT UPPER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
43 SEMBIAN RIGHT UPPER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
44 ZAIMUNISHA LEFT LOWER LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE POSITIVE 
NOT  
CONTRIBUTOR
Y   
45 JAYAKUMAR LEFT LOWER LOBE 
INTRALUMINAL 
MASS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
46 RAJESWARI RIGHT MIDDLE LOBE PURULENT SECRETIONS MTB DETECTED SENSITIVE 
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
47 RANGAN LEFT UPPER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
48 SRINIVASAN 
DIFFUSE 
INVOLVEMENT  
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
49 SHANKAR RIGHT LOWER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
50 TAMILARASI 
DIFFUSE 
INVOLVEMENT 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
51 GOVINASAMY RIGHT LOWER LOBE INTRALUMINAL MASS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
52 NALLI RIGHT LOWER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
53 RAVI LEFT UPPER LOBE PURULENT SECRETIONS 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
54 RAAKAIAH RIGHT LOWER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
55 MALA RIGHT UPPER LOBE 
MUCOSAL 
INFLAMMATION 
MTB NOT 
DETECTED   
NEGATIV
E 
NOT  
CONTRIBUTOR
Y   
                  
 
  
 
 
 
ID NAME BAL CYTOLOGY 
BAL FUNGAL 
SMEAR 
BAL CELL 
COUNT 
ENDOBRONCHIAL  
BIOPSY 
DONE OR NOT 
ENDOBRONCHIAL 
BIOPSY 
CONTRIBUTORY 
OR NOT 
TBLB 
DONE 
OR 
NOT 
IF DONE 
TBLB 
CONTIRIBUTORY  
OR NOT 
31 KALIYARAJ 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   DONE CONTRIBUTORY 
32 DURAISAMY 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY LYMPHOCYTIC DONE CONTRIBUTORY 
NOT 
DONE   
33 PITCHAIKANNU 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
34 MOORTHY 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
35 POOTHATHAN 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
36 SANTHAIYAH 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
37 SAIDA BANU 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
38 PONNUSAMY 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   DONE CONTRIBUTORY 
39 RANJITH PASWAN 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
40 ANJALAI 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
41 PERUMAL 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY EOSINOPHILIC DONE CONTRIBUTORY 
NOT 
DONE   
42 BALAKRISHNAN 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY EOSINOPHILIC NOT DONE   
NOT 
DONE   
43 SEMBIAN 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
44 ZAIMUNISHA 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
45 JAYAKUMAR 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC DONE CONTRIBUTORY 
NOT 
DONE   
46 RAJESWARI 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
47 RANGAN 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY MACROPHAGE NOT DONE   
NOT 
DONE   
48 SRINIVASAN 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   DONE CONTRIBUTORY 
49 SHANKAR 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY EOSINOPHILIC NOT DONE   
NOT 
DONE   
50 TAMILARASI 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY 
MACROPHAGE(PIGMENT 
LADEN) NOT DONE   
NOT 
DONE   
51 GOVINASAMY 
ATYPICAL CELLS 
SEEN 
NOT  
CONTRIBUTORY NEUTROPHILIC DONE CONTRIBUTORY 
NOT 
DONE   
52 NALLI 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
53 RAVI 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY LYMPHOCYTIC NOT DONE   
NOT 
DONE   
54 RAAKAIAH 
ACUTE 
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
55 MALA 
CHRONIC  
INFLAMMATORY 
PATHOLOGY 
NOT  
CONTRIBUTORY NEUTROPHILIC NOT DONE   
NOT 
DONE   
                  
 
  
 
 
 
ID NAME 
TTNA 
DONE 
OR 
NOT 
IF DONE 
TTNA 
CONTRIBUTO
RY 
OR NOT 
CT 
GUIDED 
BIOPSY 
DONE 
OR NOT 
CT GUIDED 
BIOPSY 
CONTRIBUTO
RY OR NOT 
POST FOB 
AFB 
POST FOB 
CYTOLOGY 
ETIOLOGY  
DIAGNOSE
D OR NOT DIAGNOSIS 
31 KALIYARAJ 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
 BACTERIAL PNEUMONIA 
ACTINOMYCETES 
32 DURAISAMY 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY CONTRIBUTORY YES 
SQUAMOUS CELL CARCINOMA 
(MODERATELY 
DIFFERENTIATED 
33 PITCHAIKANNU 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
BACTERIAL  
PNEUMONIA(KLEBSIELLA) 
34 MOORTHY 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES SLE PNEUMONITIS 
35 POOTHATHAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES TUBERCULOSIS 
36 SANTHAIYAH 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES TUBERCULOSIS 
37 SAIDA BANU 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
CHRONIC HSP 
(BIRD FANCIERS LUNG) 
38 PONNUSAMY 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES BOOP 
39 
RANJITH 
PASWAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
BACTERIAL  
PNEUMONIA 
40 ANJALAI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES TUBERCULOSIS 
41 PERUMAL 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
FUNGAL PNEUMONIA 
(MUCOR) 
42 BALAKRISHNAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES ABPA 
43 SEMBIAN 
NOT 
DONE   DONE 
CONTRIBUTO
RY  
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
BRONCHOALVEOLAR 
CARCINOMA 
44 ZAIMUNISHA 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES TUBERCULOSIS 
45 JAYAKUMAR 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
SQUAMOUS CELL CARCINOMA 
(POORLY DIFFERENTIATED) 
46 RAJESWARI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES TUBERCULOSIS 
47 RANGAN 
NOT 
DONE   DONE 
CONTRIBUTO
RY  
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES LIPOID PNEUMONIA 
48 SRINIVASAN 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES 
CHRONIC HSP 
(FARMERS LUNG) 
49 SHANKAR 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES ABPA 
50 TAMILARASI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY YES SILICOSIS 
51 GOVINASAMY 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY CONTRIBUTORY YES SMALL CELL CARCINOMA 
52 NALLI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY NO UNDIAGNOSED 
53 RAVI 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY NO UNDIAGNOSED 
54 RAAKAIAH 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY NO UNDIAGNOSED 
55 MALA 
NOT 
DONE   
NOT 
DONE   
NOT  
CONTRIBUTORY 
NOT  
CONTRIBUTORY NO UNDIAGNOSED 
 
